DuPont de Nemours Inc (DD)

DuPont Announces Reverse Stock Split and Reaffirms 2026 Financial GuidanceMay 26, 2026 4:15 PM
PR Newswire (US) WILMINGTON, Del., May 26, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Board of Directors has approved a reverse stock split of the Company's common stock, par value $0.01 per share, at a ratio of 1-for-3 as well as a reduction in the number of authorized shares of its common stock by a corresponding ratio (the "Reverse Stock Split"). The Reverse Stock Split was approved by stockholders at the Company's 2026 Annual Meeting of Stockholders held on May 21, 2026, and is expected to become effective at 12:01 a.m. Eastern Time on June 24, 2026. DuPont's common stock is expected to begin trading on a split-adjusted basis on the New York Stock Exchange on June 24, 2026 under the existing ticker symbol "DD" with a new CUSIP number of 26614N 201.At the effective time of the Reverse Stock Split, every three issued and outstanding shares of DuPont common stock will be automatically combined into one share of common stock. In addition, the total number of shares of the Company's common stock authorized for issuance will be reduced from 1,666,666,667 to 555,555,556. If the Reverse Stock Split were implemented as of May 22, 2026, the total number of outstanding shares would be reduced proportionately from approximately 405,058,202 to approximately 135,019,401, subject to adjustment for fractional shares.No fractional shares will be issued in connection with the Reverse Stock Split. Stockholders who would otherwise be entitled to receive fractional shares will receive a cash payment from Computershare Trust Company, N.A., the Company's transfer agent, in lieu thereof. Proportionate adjustments will be made to the number of shares underlying the Company's outstanding equity awards, including stock options and restricted stock units, and to the exercise or conversion prices of such instruments. Similar adjustments will be made to outstanding warrants and other convertible securities. The Reverse Stock Split will not affect any stockholder's proportionate ownership interest in the Company, except for adjustments resulting from the treatment of fractional shares. Stockholders holding shares in book-entry form or through a bank, broker, or other nominee will have their holdings automatically adjusted to reflect the Reverse Stock Split. Stockholders holding physical certificates will receive instructions from the Company's transfer agent regarding exchange procedures. The Company today also reaffirmed its second quarter and full year 2026 financial guidance for net sales, operating EBITDA and adjusted EPS, and intends to present its per share metrics, including earnings per share, on a split-adjusted basis when reported. Below represents our adjusted earnings per share guidance, giving effect to the Reverse Stock Split which results in a weighted average diluted share count for the second quarter and full year 2026 of approximately 137 million shares:
2Q'26EFull Year 2026EAdjusted EPS(1) – Prior Guidance~$0.59$2.35 - $2.40Adjusted EPS(1) – Effect of Reverse Stock Split~$1.75$7.02 - $7.16Adjusted Earnings Per Share is a non-GAAP measures and only reflects continuing operations. The Company has not provided forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to do so without unreasonable effort or expense, including due to the fact that the Company is unable to predict with reasonable certainty the ultimate outcome of certain future events. These events include, among others, the impact of portfolio changes, including asset sales, mergers, acquisitions, and divestitures; contingent liabilities related to litigation, environmental and indemnifications matters; impairments and discrete tax items. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period. The most directly comparable U.S. GAAP financial measure to Adjusted Earnings Per Share is Earnings Per Share.About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.DuPont™ and all products, unless otherwise noted, denoted with ™, SM or ® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc.Cautionary Statement Regarding Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target, "outlook," "stabilization," "confident," "preliminary," "initial," and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements, including statements regarding outlook, expectations and guidance.? Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements.  Forward-looking statements are not guarantees of future results. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-announces-reverse-stock-split-and-reaffirms-2026-financial-guidance-302782285.htmlSOURCE DuPont Original: DuPont Announces Reverse Stock Split and Reaffirms 2026 Financial Guidance

DuPont Wins 2026 IRI Innovation Excellence AwardMay 8, 2026 9:00 AM
PR Newswire (US) Recognized for leadership in enterprise-wide culture that enables innovation at scaleWILMINGTON, Del., May 8, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced it was named the co-winner, along with Qnity Electronics, of the 2026 Innovation Excellence Award for Outstanding Innovative Culture from the Innovation Research Interchange (IRI), the innovation division of the National Association of Manufacturers (NAM). "Innovation doesn't happen by accident—it occurs when people are empowered, connected and supported," said Marty DeGroot, DuPont Chief Technology Officer. "We're honored by this recognition, which reflects our commitment to delivering sustainable innovations for our customers, and fostering a culture where diverse perspectives, collaboration and continuous learning help turn ideas into scalable solutions with real-world impact."DuPont and Qnity Electronics were named co-winners of the IRI Excellence Award for Outstanding Innovative Culture, which recognizes companies that empower employees at all levels, support inclusive and psychologically safe workplaces, and sustain innovation through leadership behaviors, systems and talent development. The DuPont/ Qnity submission, From "Know it All" to "Learn it All": DuPont and Qnity's Lean Innovation Culture Journey, was recognized for its work embedding innovation across science, sustainability, digital capabilities and manufacturing, supported by enterprise-scale collaboration.DuPont Water Solutions was also named a Finalist for the IRI Excellence Award for Innovation in Sustainability for its Minimal Liquid Discharge (MLD) portfolio, powered by FilmTec™ Fortilife™ reverse osmosis elements. The MLD portfolio addresses one of industry's most complex challenges: making high-salinity wastewater reuse more practical, energy-efficient and cost-effective. By pairing advanced membrane technology with thermal processes, DuPont's MLD approach reduces the volume of wastewater requiring energy-intensive treatment, enabling higher water recovery, lower energy consumption and reduced environmental impact.The IRI Innovation Excellence Awards are presented annually by the Innovation Research Interchange (IRI), a division of the National Association of Manufacturers (NAM). The program recognizes companies and teams advancing industry, science and society through impactful research, development and innovation practices. Founded in 1938 (formerly the Industrial Research Institute), IRI is an inclusive membership organization of nearly 100 global private-sector companies and federally funded laboratories focused on advancing innovation management.About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ? or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted. View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-wins-2026-iri-innovation-excellence-award-302766335.htmlSOURCE DuPont Original: DuPont Wins 2026 IRI Innovation Excellence Award

DuPont Shares Rise on Earnings Beat and Upgraded OutlookMay 5, 2026 7:44 AM
IH Market News DuPont de Nemours Inc. (NYSE:DD) reported first-quarter results that came in ahead of expectations and lifted its full-year guidance, driving its shares up 4.6% in premarket trading.The company posted adjusted earnings per share of $0.55, surpassing the consensus estimate of $0.49 by $0.06. Revenue totaled $1.68 billion, beating forecasts of $1.66 billion and reflecting a 4% increase from the same period last year. Organic sales rose 2% year-on-year, with an additional 2% boost from currency effects contributing to overall growth. Guidance Edges Higher For the second quarter, DuPont expects adjusted EPS of about $0.59, slightly above the $0.58 consensus, while revenue is projected at roughly $1.8 billion, broadly in line with analyst expectations.The company also raised its full-year 2026 outlook, now forecasting adjusted EPS between $2.35 and $2.40, with a midpoint of $2.375—above the $2.27 consensus. Full-year revenue guidance was lifted to a range of $7.16 billion to $7.22 billion, exceeding the $7.1 billion estimate, with a midpoint of $7.19 billion. Strong Start to the Year “We delivered a strong start to the year, exceeding our financial guidance through disciplined commercial and operational execution,” said Lori Koch. “Our teams remained focused on our customers and delivered organic growth, margin expansion, and double-digit adjusted EPS growth, along with solid cash flow generation in the quarter.” Segment Performance The Healthcare & Water Technologies division recorded net sales of $806 million, a 6% increase from a year earlier, including 3% organic growth. Healthcare Technologies saw high-single-digit growth, supported by demand in medical packaging and biopharma applications.Meanwhile, the Diversified Industrials segment generated $875 million in revenue, up 3% year-on-year. Organic sales in this segment were flat, as gains in aerospace and automotive were offset by softer demand in construction markets. Profitability Improves Operating EBITDA rose 15% to $414 million, while margins expanded by 230 basis points to 24.6%, reflecting improved efficiency and operating performance.DuPont de Nemours stock price Original: DuPont Shares Rise on Earnings Beat and Upgraded Outlook

DuPont Reports First Quarter 2026 ResultsMay 5, 2026 6:00 AM
PR Newswire (US) Exceeds First Quarter 2026 Guidance
Raises Full Year 2026 GuidanceFirst Quarter 2026 HighlightsNet Sales of $1.7 billion increased 4%; organic sales increased 2% versus year-ago periodGAAP Income from continuing operations of $150 million; operating EBITDA of $414 millionGAAP EPS from continuing operations of $0.36; adjusted EPS of $0.55Cash provided by operating activities from continuing operations of $232 million; transaction-adjusted free cash flow of $147 millionCompleted the previously announced divestiture of the Aramids business on April 1stAnnounces $275 million accelerated share repurchase expected to be launched imminentlyWILMINGTON, Del., May 5, 2026 /PRNewswire/ -- DuPont (NYSE: DD) announced its financial results(1) for the first quarter ended March 31, 2026 and raised financial guidance for the full year 2026.  "We delivered a strong start to the year, exceeding our financial guidance through disciplined commercial and operational execution" said Lori Koch, DuPont Chief Executive Officer. "Our teams remained focused on our customers and delivered organic growth, margin expansion, and double-digit adjusted EPS growth, along with solid cash flow generation in the quarter.""Our strategic priorities are clear and we remain focused on value creation by serving our customers, driving commercial and operational excellence and allocating capital thoughtfully to deliver consistent performance to our shareholders," Koch concluded.First Quarter 2026 Consolidated Results(1) Dollars in millions, except EPS1Q'261Q'25Changevs. 1Q'25Organic Sales (2)vs. 1Q'25Net sales$1,681$1,6124 %2 %GAAP Income from continuing operations$150$8088 %
Operating EBITDA(2)$414$36015 %
Operating EBITDA margin(2) %24.6 %22.3 %230 bps
GAAP EPS from continuing operations$0.36$0.1989 %
Adjusted EPS(2)$0.55$0.3653 %
Cash provided by operating activities – cont. ops.$232$77201 %
Transaction-adjusted free cash flow(2)$147$8n.m
Net salesNet sales were up 4% on a 2% increase in organic sales and a 2% currency benefit.3% organic sales growth in Healthcare & Water Technologies; about flat organic sales growth in Diversified Industrials.GAAP Income from continuing operationsGAAP Income/GAAP EPS from continuing operations improved on higher segment earnings and lower interest expense, partially offset by the absence of a prior year gain on interest rate swaps.Operating EBITDAOperating EBITDA increased on organic growth, favorable mix and productivity.Adjusted EPSAdjusted EPS increased on higher segment earnings and lower interest expense, corporate costs and tax rate.Cash provided by operating activities from continuing operationsCash provided by operating activities from continuing operations in the quarter of $232 million, capital expenditures of $102 million and separation-related transaction costs and other payments of $17 million resulted in transaction-adjusted free cash flow and related conversion of $147 million and 65%, respectively.(1)Results and cash flows are presented on a continuing operations basis. See page 6 for further information, including the basis of presentation included in this release.(2)Organic sales, operating EBITDA, operating EBITDA margin, adjusted EPS, transaction-adjusted free cash flow and transaction-adjusted free cash flow conversion are non-GAAP measures and only reflect continuing operations. See page 6 for further discussion, including a definition of significant items. Reconciliation to the most directly comparable GAAP measure, including details of significant items begins on page 13 of this communication. First Quarter 2026 Segment Highlights Healthcare & Water Technologies Dollars in millions1Q'261Q'25Changevs. 1Q'25Organic Sales(2)vs. 1Q'25Net sales$806$7636 %3 %Operating EBITDA$244$2239 %
Operating EBITDA margin %30.3 %29.2 %110 bps
Net salesNet sales increased 6% on organic sales growth of 3% and a currency benefit of 3%.Healthcare Technologies sales up high-single digits on an organic basis on broad-based growth led by medical packaging and biopharma.Water Technologies sales down low to mid-single digits on an organic basis as strength in industrial water and microelectronics markets were more than offset by logistics disruptions in the Middle East.   Operating EBITDAOperating EBITDA increased on organic growth and productivity.Operating EBITDA margin of 30.3% increased 110 basis points on organic growth, favorable mix and productivity. Diversified Industrials Dollars in millions1Q'261Q'25Changevs. 1Q'25Organic Sales(2)vs. 1Q'25Net sales$875$8493 %~flatOperating EBITDA$200$1858 %
Operating EBITDA margin %22.9 %21.8 %110 bps
Net salesNet sales increased 3% on a currency benefit of 3%. Organic sales were about flat in the quarter.Building Technologies sales down low-single digits on an organic basis from ongoing weakness in construction markets.Industrial Technologies sales up low-single digits on an organic basis on strength in aerospace and automotive, partially offset by declines in the printing and packaging businesses.Operating EBITDAOperating EBITDA increased on favorable mix and productivity.Operating EBITDA margin of 22.9% increased 110 basis points on favorable mix and productivity. 2026 Financial Outlook Dollars in millions, except EPS



2Q'26EFull Year 2026ENet sales



~$1,800$7,155 - $7,215Operating EBITDA(2)



~$430$1,730 - $1,760Adjusted EPS(2)



~$0.59$2.35 - $2.40"For the second quarter 2026, we estimate net sales of about $1.8 billion, operating EBITDA of about $430 million and adjusted EPS of approximately $0.59 per share," said Antonella Franzen, DuPont Chief Financial Officer. "Our second quarter guidance estimates organic sales growth of about 3%, with currency a slight tailwind in the quarter.""We are raising our full year 2026 guidance given our strong start to the year and the interest income benefit from the Aramids transaction. In addition, our full year net sales guidance now assumes about 4% organic growth including about 1% of pricing due to actions taken to fully offset higher input costs related to the Middle East conflict," Franzen concluded.Conference Call
The Company will host a live webcast of its quarterly earnings conference call with investors to discuss its results and business outlook beginning today at 8:00 a.m. ET. The slide presentation that accompanies the conference call will be posted on the DuPont's Investor Relations Events and Presentations page. A replay of the webcast also will be available on the DuPont's Investor Relations Events and Presentations page following the live event.About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.DuPont™ and all products, unless otherwise noted, denoted with ™, SM or ® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc.Overview
On April 1, 2026, DuPont completed the sale of the Aramids business (the "Aramids Business" and the divestiture of the Aramids Business, the "Aramids Divestiture") to Arclin, a portfolio company of an affiliate of TJC LP, ("TJC"), for pre-tax cash proceeds of approximately $1.2 billion, subject to customary transaction adjustments, a note receivable in the principal amount of $300 million and a non-controlling common equity interest (the "Aramids Equity Consideration"), valued at $325 million, in New Arclin U.S. Holding Corp., which now owns the Arclin global materials business and the Aramids Business. The financial results of the divested Aramids Business are reflected in DuPont's interim Consolidated Financial Statements as discontinued operations, along with comparative periods.On March 18, 2026, the Company announced that it plans to seek approval at its 2026 Annual Meeting of Stockholders for an amendment to the Company's Third Amended and Restated Certificate of Incorporation (the "Certificate of Incorporation") to effect, at the discretion of DuPont's Board of Directors (the "Board of Directors"), a reverse stock split of the Company's common stock, par value $0.01 per share, at a ratio of not less than 1-for-2 or more than 1-for-4, with the exact ratio to be determined by the Board of Directors at a later date (the "Intended Reverse Stock Split"). If and when the Intended Reverse Stock Split is effected, the Certificate of Incorporation will also be amended to reflect a corresponding reduction in the number of authorized shares of the Company's common stock by the selected reverse stock split ratio. The interim Consolidated Financial Statements have not been retrospectively adjusted to reflect the Intended Reverse Stock Split, which remains subject to stockholder approval.On November 1, 2025, DuPont completed the separation of its semiconductor and interconnect solutions businesses (the "Electronics Business" and the separation of the Electronics Business, the "Electronics Separation") into an independent public company, Qnity Electronics, Inc. ("Qnity"), by way of the distribution to DuPont's stockholders of record as of October 22, 2025 of all the issued and outstanding common stock of Qnity on November 1, 2025 (the "Qnity Distribution"). As a result, the financial results of the divested Electronics Business, are reflected in the comparative period of DuPont's interim Consolidated Financial Statements as discontinued operations.Cautionary Statement Regarding Forward-looking Statements
Certain statements in this release may be considered forward-looking statements, within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements often contain words such as "expect", "anticipate", "intend", "plan", "believe", "seek", "see", "will", "would", "target", "outlook", "stabilization", "confident", "preliminary", "initial", "continue", "may", "could", "project", "estimate", "forecast" and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements. Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements.Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to (i) the ability to realize the intended benefits of the Electronics Separation and the Qnity Distribution, including achievement of the intended tax treatment, contractual allocation to, and assumption by Qnity of certain liabilities, including certain legacy liabilities with respect to per- and polyfluoroalkyl substances ("PFAS") and the possibility of disputes, litigation or unanticipated costs in connection with the Electronics Separation and Qnity Distribution; (ii) the impact of the Aramids Divestiture on DuPont's balance sheet, financial condition and future results of operations; (iii) risks and costs related to the impact of the arrangement to share future eligible PFAS costs by and among DuPont, Corteva, Inc. and The Chemours Company, including the outcome of pending or future litigation related to PFAS or PFOA, which includes personal injury claims and natural resource damages claims; the extent and cost of ongoing and potential future remediation obligations; and changes in laws and regulations applicable to PFAS chemicals; (iv) the failure to realize expected benefits and effectively manage and achieve anticipated synergies and operational efficiencies in connection with the Electronics Separation, the Aramids Divestiture and completed and future, if any, divestitures, mergers, acquisitions, and other portfolio management, productivity and infrastructure actions; (v) risks and uncertainties that are outside the Company's control but adversely impact the overall environment in which DuPont, its customers and/or its suppliers operate, including changes in economic, political, regulatory, international trade, geopolitical, military conflicts, capital markets and other external conditions, including pandemics and responsive actions, as well as natural and other disasters or weather-related events; (vi) the ability to offset increases in cost of inputs, including raw materials, energy and logistics; (vii) the risks and uncertainties associated with continuing or expanding geopolitical conflicts or trade disputes or restrictions and responsive actions, new or increased tariffs or export controls, including on exports to China of U.S.-regulated products and technology; (viii) other risks to DuPont's business and operations, including the risk of impairment; (ix) risks and uncertainties in connection with completing the $2 billion share buyback announced on November 6, 2025, including timeline, associated costs and the possibility that the authorization may be suspended or discontinued prior to completion; (x) the ability to implement, and realize the intended benefits of, the Intended Reverse Stock Split; (xi) the impact of the invalidation of certain tariffs imposed under the International Emergency Economic Powers Act and (xii) other risk factors discussed in DuPont's most recent annual report on Form 10-K, and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with the U.S. Securities and Exchange Commission.Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business or supply chain disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont's consolidated financial condition, results of operations, credit rating or liquidity. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.Non-GAAP Financial MeasuresUnless otherwise indicated, all financial metrics presented reflect continuing operations only.This communication includes information that does not conform to accounting principles generally accepted in the United States of America ("U.S. GAAP") and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company, including allocating resources. DuPont's management believes these non-GAAP financial measures are useful to investors because they provide additional information related to the ongoing performance of DuPont to offer a more meaningful comparison related to future results of operations. These non-GAAP financial measures supplement disclosures prepared in accordance with U.S. GAAP, and should not be viewed as an alternative to U.S. GAAP. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Reconciliations for these Non-GAAP measures to U.S. GAAP are provided in the Selected Financial Information and Non-GAAP Measures starting on page 12. Non-GAAP measures included in this communication are defined below. The Company has not provided forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of certain future events. These events include, among others, the impact of portfolio changes, including asset sales, mergers, acquisitions, and divestitures; contingent liabilities related to litigation, environmental and indemnifications matters; impairments and discrete tax items. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.Key TermsSignificant ItemsSignificant items are items that arise outside the ordinary course of business for the Company and includes items for nonconsolidated affiliates, that the Company's management believes may cause misinterpretation of underlying business and investment performance, both historical and future, based on a combination of some or all of the item's size, unusual nature and infrequent occurrence. Management classifies as significant items certain costs and expenses associated with integration and separation activities related to transformational acquisitions and divestitures as they are considered unrelated to ongoing business performance. There were no significant items associated with nonconsolidated affiliates recorded for the three month periods ended March 31, 2026 and March 31, 2025.Future Reimbursable Indirect CostsIndirect costs, such as those related to corporate and shared service functions previously allocated to the separated Electronics Business and Aramids Business, do not meet the criteria for discontinued operations and are reported within continuing operations in all respective periods presented. The Company has, is, will or expects to be reimbursed in accordance with the applicable transition service agreements ("TSAs") for the portion of indirect costs related to activities the Company is, will or expects to undertake on a transitional basis to support a) Qnity not beyond year end 2027 for services and 2040 for site leases and, b) the Aramids Business post the intended Aramids Divestiture, but not beyond 2028 (such indirect costs "Future Reimbursable Indirect Costs"). Services provided and costs reimbursed in accordance with the applicable TSAs include but are not limited to, costs associated with information technology services/support, product stewardship and regulatory support, facilities services, and shared property lease costs.Future Reimbursable Indirect Costs do not meet the criteria for discontinued operations and therefore are included in both GAAP Net Income from Continuing Operations and in GAAP Cash provided by operating activities-continuing operations for all periods presented. Future Reimbursable Indirect Costs are excluded from Adjusted Earnings, Operating EBITDA and Transaction-Adjusted Free Cash Flow, each defined below. Such indirect costs that are not subject to future reimbursement are reported within continuing operations in Corporate and are included within Adjusted Earnings, Operating EBITDA, and Cash provided by operating activities-continuing operations.Corporate DDOB Remediation CostsCorporate DDOB Remediation Costs are environmental remediation costs, including certain investigate, remediate and restoration costs, associated with discontinued or divested operations, businesses or product lines ("Corporate DDOB Remediation Costs"). DDOB Remediation Costs are excluded from Adjusted Earnings and Operating EBITDA, as defined below, to provide better insight into the underlying business performance of the Company.Non-GAAP Measure DefinitionsOrganic SalesOrganic Sales is defined as net sales excluding the impacts of currency and portfolio.Adjusted EarningsAdjusted Earnings is defined as income from continuing operations excluding the after-tax impact of significant items, after-tax impact of amortization expense of intangibles, the after-tax impact of non-operating pension / other post employment benefits ("OPEB") credits / costs, Future Reimbursable Indirect Costs and Corporate DDOB Remediation Costs.Adjusted Earnings is the numerator used in the calculation of Adjusted EPS, as well as the denominator in Adjusted Free Cash Flow Conversion.Adjusted EPSAdjusted EPS is defined as Adjusted Earnings per common share - diluted. Management estimates amortization expense in 2026 associated with intangibles to be about $275 million on a pre-tax basis, or approximately $0.51 per share.Operating EBITDA, EBITDA Margin & Incremental MarginThe Company's measure of profit/loss for segment reporting purposes is Operating EBITDA as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines Operating EBITDA as earnings (i.e., "Income from continuing operations before income taxes") before interest, depreciation, amortization, non-operating pension / OPEB benefits / charges, and foreign exchange gains / losses, excluding Future Reimbursable Indirect Costs, Corporate DDOB Remediation Costs, and adjusted for significant items. Reconciliations of these measures are provided on the following pages.Operating EBITDA Margin is defined as Operating EBITDA divided by Net Sales.Incremental Margin is the change in Operating EBITDA divided by the change in Net Sales for the applicable period.Adjusted Free Cash Flow & Adjusted Free Cash Flow Conversion Adjusted Free Cash Flow is defined as cash provided by/used for operating activities from continuing operations less capital expenditures and excluding the impact of cash inflows/outflows that are unusual in nature and/or infrequent in occurrence that neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business liquidity. As a result, Adjusted Free Cash Flow represents cash that is available to the Company, after investing in its asset base, to fund obligations using the Company's primary source of liquidity, cash provided by operating activities from continuing operations. Management believes Adjusted Free Cash Flow, even though it may be defined differently from other companies, is useful to investors, analysts and others to evaluate the Company's cash flow and financial performance, and it is an integral measure used in the Company's financial planning process. Management notes that there were no exclusions for items that are unusual in nature and/or infrequent in occurrence for the three month period ended March 31, 2026.Adjusted Free Cash Flow Conversion is defined as Adjusted Free Cash Flow divided by Adjusted Earnings. Management uses Adjusted Free Cash Flow Conversion as an indicator of our ability to convert earnings to cash.Transaction Adjusted Free Cash Flow & Transaction Adjusted Free Cash Flow Conversion Management believes supplemental non-GAAP financial measures including Transaction-Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow Conversion (each defined below) provide an integral view of information on the Company's underlying business performance during this period of transformational change. Management believes the Electronics Separation and Aramids Divestiture collectively represent a significant transformational change for the Company and separation-related transaction cost payments impact comparability to the Company's continuing operations. Management believes Transaction-Adjusted Free Cash Flow, which may be defined differently from other companies, is useful to investors, analysts and others to evaluate the Company's cash flow and financial performance, and it is an integral measure used in the Company's financial planning process. These non-GAAP financial measures are not intended to represent residual cash flow for discretionary expenditures since other non-discretionary expenditures, such as mandatory debt service requirements, are not deducted from the measure.Transaction-Adjusted Free Cash Flow is defined as cash provided by/used for operating activities from continuing operations less capital expenditures and removing the impact of separation-related transaction costs and other payment and cash inflows/outflows that are unusual in nature and/or infrequent in occurrence that neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business liquidity.Transaction-Adjusted Free Cash Flow Conversion is defined as Transaction-Adjusted Free Cash Flow excluding separation-related transaction costs, divided by Adjusted Earnings.Separation-related transaction costs and other payments include cash outflows directly associated with the Electronics Separation and the Aramids Divestiture. These costs include advisor and banking fees, payments related to establishing a new capital structure (including fees associated with interest rate swaps), capital expenditures required to facilitate physical asset separation, restructuring payments associated with senior leadership, and Future Reimbursable Indirect Costs, among other expenditures.Future Reimbursable Indirect Costs are excluded from Adjusted Earnings and Operating EBITDA. To provide comparable data analysis, the Company has also adjusted payments associated with Future Reimbursable Indirect Costs within Separation-related transaction costs and other payments. This adjustment is intended to provide insight into the Company's underlying business performance. For the three months ended March 31, 2026, the Company adjusted $8 million associated with Future Reimbursable Indirect Costs within Separation-related transaction costs and other payments.Additionally, $3 million was reflected in Separation-related transaction costs and other payments for the three month period ended March 31, 2026, respectively, for capital expenditures incurred to complete the physical separation of shared locations.Finally, $6 million of restructuring and short-term incentive program payments to former senior leadership were reflected in Separation-related transaction costs and other payments for the three month period ended March 31, 2026. These payments were reflected in other cash payments as they related to the establishment of the post-spin leadership structure.DuPont de Nemours, Inc.Consolidated Statements of Operations 
Three Months Ended March 31,In millions, except per share amounts (Unaudited)20262025Net sales$                   1,681$                   1,612Cost of sales1,0791,069Research and development expenses4750Selling, general and administrative expenses255234Amortization of intangibles6875Restructuring and asset related charges - net4639Acquisition, integration and separation costs—50Equity in loss of nonconsolidated affiliates(1)(15)Sundry income (expense) - net36100Interest expense4083Income from continuing operations before income taxes$                     181$                        97Provision for income taxes on continuing operations3117Income from continuing operations, net of tax$                     150$                        80Income (loss) from discontinued operations, net of tax14(661)Net income (loss) $                     164$                    (581)Net income attributable to noncontrolling interests38Net income (loss) available for DuPont common stockholders$                     161$                    (589)





Per common share data:

Earnings per common share from continuing operations - basic$                    0.36$                    0.19Earnings (loss) per common share from discontinued operations - basic0.03(1.59)Earnings (loss) per common share - basic$                    0.39$                   (1.41)Earnings per common share from continuing operations - diluted$                    0.36$                    0.19Earnings (loss) per common share from discontinued operations - diluted0.03(1.59)Earnings (loss) per common share - diluted$                    0.39$                   (1.40)


Weighted-average common shares outstanding - basic410.1418.5Weighted-average common shares outstanding - diluted412.8419.9 DuPont de Nemours, Inc.Condensed Consolidated Balance Sheets In millions, except share amounts (Unaudited)March 31, 2026December 31, 2025Assets

Current Assets

Cash and cash equivalents$                     710$                     715Restricted cash and cash equivalents4242Accounts and notes receivable - net1,6991,669Inventories1,2091,172Prepaid and other current assets130121Assets of discontinued operations1,8531,856Total current assets$                   5,643$                   5,575Property, plant and equipment - net of accumulated depreciation (March 31,
2026 - $3,634; December 31, 2025 - $3,565)3,4263,464Other Assets

Goodwill7,8657,915Other intangible assets2,8602,936Investments and noncurrent receivables452432Deferred income tax assets264282Deferred charges and other assets939971Total other assets$                 12,380$                 12,536Total Assets$                 21,449$                 21,575Liabilities and Equity

Current Liabilities

Short-term borrowings$                      40$                      60Accounts payable882995Income taxes payable4954Accrued and other current liabilities833882Liabilities of discontinued operations299314Total current liabilities$                   2,103$                   2,305Long-Term Debt3,1323,134Other Noncurrent Liabilities

Deferred income tax liabilities378405Pension and other post-employment benefits - noncurrent414432Other noncurrent obligations1,1841,196Total other noncurrent liabilities$                   1,976$                   2,033Total Liabilities$                   7,211$                   7,472Commitments and contingent liabilities

Stockholders' Equity

Common stock (authorized 1,666,666,667 shares of $0.01 par value each;
     issued 2026: 409,867,418 shares; 2025: 409,195,445 shares)44Additional paid-in capital38,84938,718Accumulated deficit(24,201)(24,278)Accumulated other comprehensive loss(612)(525)Total DuPont stockholders' equity$                 14,040$                 13,919Noncontrolling interests198184Total equity$                 14,238$                 14,103Total Liabilities and Equity$                 21,449$                 21,575 DuPont de Nemours, Inc.Consolidated Statement of Cash Flows 
Three Months Ended March 31,In millions (Unaudited)20262025Operating Activities

Net income (loss)$                164$               (581)Income (loss) from discontinued operations14(661)Net income from continuing operations$                150$                 80Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization155160Credit for deferred income tax and other tax related items(12)(5)Losses of nonconsolidated affiliates plus dividends received216Net periodic pension benefit costs31Periodic benefit plan contributions(12)(13)Restructuring and asset related charges - net4639Interest rate swap gain—(78)Stock based compensation137Donatelle contingent earn-out true-up(6)—Other net income(3)(6)Changes in assets and liabilities, net of effects of acquired and divested companies:

Accounts and notes receivable23(45)Inventories(48)(49)Accounts payable(6)(8)Other assets and liabilities, net(73)(22)Cash provided by operating activities - continuing operations$                232$                 77Investing Activities

Capital expenditures(102)(122)Other investing activities, net—2Cash used for investing activities - continuing operations$               (102)$               (120)Financing Activities

Changes in short-term borrowings(20)—Proceeds from issuance of Company stock844Employee taxes paid for share-based payment arrangements(16)(16)Distributions to noncontrolling interests(11)(5)Dividends paid to stockholders(82)(172)Other financing activities, net1—Cash used for financing activities - continuing operations$                (44)$               (189)Cash Flows from Discontinued Operations

Cash (used for) provided by operations - discontinued operations(79)274Cash used for investing activities - discontinued operations(6)(127)Cash used for financing activities - discontinued operations(3)(17)Cash (used for) provided by discontinued operations$                (88)$                130Effect of exchange rate changes on cash, cash equivalents and restricted cash(5)13Decrease in cash, cash equivalents and restricted cash$                 (7)$                (89)Cash, cash equivalents and restricted cash from continuing operations, beginning of period7571,834Cash, cash equivalents and restricted cash from discontinued operations, beginning of period358Cash, cash equivalents and restricted cash at beginning of period$                760$              1,892Cash, cash equivalents and restricted cash from continuing operations, end of period7521,752Cash, cash equivalents and restricted cash from discontinued operations, end of period151Cash, cash equivalents and restricted cash at end of period$                753$              1,803 DuPont de Nemours, Inc.Select Segment Information and Non-GAAP Measures Net Sales by SegmentThree Months EndedIn millions (Unaudited)Mar 31, 2026Mar 31, 2025Healthcare & Water Technologies$                             806$                             763Diversified Industrials875849Total$                           1,681$                           1,612 Net Sales Variance by SegmentThree Months Ended March 31, 2026Organic SalesCurrencyPortfolio /
OtherTotalPercent change from prior year (Unaudited)Healthcare & Water Technologies3 %3 %— %6 %Diversified Industrials—3—3Total2 %2 %— %4 % Operating EBITDA by Segment Three Months EndedIn millions (Unaudited)Mar 31, 2026Mar 31, 2025Healthcare & Water Technologies$                             244$                             223Diversified Industrials200185Corporate 1(30)(48)Total$                             414$                             3601.  Corporate includes expenses of the Corporate function not allocated to specific business in the Company. Equity in Earnings (Loss) of Nonconsolidated Affiliates by SegmentThree Months EndedIn millions (Unaudited)Mar 31, 2026Mar 31, 2025Healthcare & Water Technologies$                                1$                              —Diversified Industrials(1)—Corporate 1(1)(15)Total equity loss included in operating EBITDA (GAAP)$                              (1)$                             (15)1.  Corporate includes the equity interest acquired in the Delrin® Divestiture transaction. DuPont de Nemours, Inc.Selected Financial Information and Non-GAAP Measures 

Reconciliation of "Income from continuing operations, net of tax" to "Operating EBITDA" Three Months EndedIn millions (Unaudited)Mar 31, 2026Mar 31, 2025Income from continuing operations, net of tax (GAAP)$                          150$                           80+ Provision for income taxes on continuing operations3117Income from continuing operations before income taxes $                          181$                           97+ Depreciation and amortization155160- Interest income 1, 21017+ Interest expense 34082- Non-operating pension/OPEB benefit credits 1—2- Foreign exchange gains (losses), net 110(3)+ Future Reimbursable Indirect Costs825+ Corporate DDOB Remediation Costs43- Significant items charge(46)(9)Operating EBITDA (non-GAAP)$                          414$                          3601.Included in "Sundry income (expense) - net".2.The three months ended March 31, 2025 excludes accrued interest income earned on employee retention credits. Refer to details of significant items on page 14.3.The three months ended March 31, 2025 excludes interest rate swap basis amortization. Refer to details of significant items on page 14. Reconciliation of "Cash provided by operating activities - continuing operations" to Adjusted Free Cash Flow 1 , Transaction-Adjusted Free Cash Flow1 and calculation of "Adjusted Free Cash Flow Conversion" and "Transaction-Adjusted Free Cash Flow Conversion"Three Months EndedIn millions (Unaudited)Mar 31, 2026Mar 31, 2025Cash provided by operating activities (GAAP) 2 - continuing operations$                        232$                        77Capital expenditures(102)(122)Adjusted free cash flow (non-GAAP)$                        130$                       (45)Separation-related transaction cost and other payments31753Transaction-adjusted free cash flow (non-GAAP)$                        147$                          8


Adjusted earnings (non-GAAP) 4$                        226$                      154Adjusted free cash flow conversion (non-GAAP)58 %(29) %Transaction-adjusted free cash flow conversion (non-GAAP)65 %5 %1.Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow are calculated on a continuing operations basis for all periods presented. Refer to the definitions of Non-GAAP metrics on pages 7-8 for additional information.2.Refer to the Consolidated Statement of Cash Flows included in the schedules above for major GAAP cash flow categories as well as further detail relating to the changes in "Cash provided by operating activities - continuing operations" for the three month periods noted.3.Other payments for the three months ended March 31, 2026 includes $6 million related to restructuring and short-term incentive program payments associated with former senior leadership, $3 million of separation-related capital expenditures and $8 million for Future Reimbursable Indirect Costs (as defined in our Non-GAAP definitions).4.Refer to page 14 for the Non-GAAP reconciliations of Net income from continuing operations available for DuPont common stockholders to Adjusted Earnings (Non-GAAP). DuPont de Nemours, Inc.Selected Financial Information and Non-GAAP Measures Significant Items Impacting Results for the Three Months Ended March 31, 2026In millions, except per share amounts (Unaudited)Pretax 1Net
Income 2EPS 3Income Statement ClassificationReported earnings (GAAP)$     181$     147$    0.36
Less: Significant items



Restructuring and asset related charges - net(46)(36)(0.08)Restructuring and asset related charges - netOther benefits (credits), net 4———Sundry income (expense) - net; Selling, general and administrative expensesIncome tax items 5—180.04Provision for income taxes on continuing operationsTotal significant items$     (46)$     (18)$   (0.04)
Less: Amortization of intangibles(68)(52)(0.13)Amortization of intangiblesLess: Future reimbursable indirect costs(8)(6)(0.01)Selling, general and administrative expensesLess: Corporate DDOB remediation costs(4)(3)(0.01)Selling, general and administrative expensesAdjusted earnings (non-GAAP)$     307$     226$    0.55

Significant Items Impacting Results for the Three Months Ended March 31, 2025In millions, except per share amounts (Unaudited)Pretax 1Net
Income 2EPS 3Income Statement ClassificationReported earnings (GAAP)$      97$      78$    0.19
Less: Significant items



Acquisition, integration and separation costs(50)(43)(0.10)Acquisition, integration and separation costsRestructuring and asset related charges - net(39)(33)(0.08)Restructuring and asset related charges - netInterest rate swap mark-to-market loss 677600.14Sundry income (expense) - net; Interest expenseOther benefits (credits), net 7330.01Sundry income (expense) - netIncome tax items 8—160.04Provision for income taxes on continuing operationsTotal significant items$      (9)$        3$    0.01
Less: Amortization of intangibles(75)(59)(0.14)Amortization of intangiblesLess: Non-op pension / OPEB benefit credits22—Sundry income (expense) - netLess: Future reimbursable indirect costs(25)(20)(0.04)Selling, general and administrative expensesLess: Corporate DDOB remediation costs(3)(2)—Selling, general and administrative expensesAdjusted earnings (non-GAAP)$     207$     154$    0.36
1.Income (loss) from continuing operations before income taxes.2.Net income (loss) from continuing operations available for DuPont common stockholders. The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.3.Earnings (loss) per common share from continuing operations - diluted.4.Includes benefits related to an adjustment of the Donatelle contingent earn-out liability ($6 million pre-tax benefit) and legal costs within the Healthcare & Water Technologies segment associated with a pending intellectual property matter ($3 million pre-tax cost), and legal costs associated with personal injury cases associated with Corian® Quartz, a product within the Diversified Industrials segment ($3 million pre-tax cost).5.Reflects the 2026 income tax benefit primarily the result of a discrete tax benefit relating to a change in tax classification of a non-U.S. legal entity ($20 million pre-tax benefit).6.The three months ended March 31, 2025 includes non-cash mark-to-market gain related to the 2022 Swaps and 2024 Swaps and the interest settlement loss on the 2022 Swaps. The three months March 31, 2025 also includes basis amortization on the 2022 Swaps ($1 million pre-tax, reflected in "Interest expense" within the Consolidated Statements of Operations).7.Reflects the accrued interest earned on employee retention credits.8.Reflects the income tax impact of certain internal restructurings related to the Electronics Separation.  View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-reports-first-quarter-2026-results-302761915.htmlSOURCE DuPont Original: DuPont Reports First Quarter 2026 Results

DuPont Publishes 2026 Sustainability ReportMay 4, 2026 8:00 AM
PR Newswire (US)

Highlights Strong Climate Progress; Announces 2035 GoalsWILMINGTON, Del., May 4, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today published its 2026 Sustainability Report, detailing significant progress in 2025 towards its climate and sustainability ambitions and introducing nine goals with deliverables through 2035.







"The progress outlined in our 2026 Sustainability Report reflects the dedication of our teams and underscores how sustainability is embedded in DuPont's strategy that drives growth, consistent execution and long-term value creation," said Scott Collick, Chief Sustainability Officer at DuPont. "The report highlights the advancements we have made in the past year to strengthen our portfolio, drive operational efficiency, and deliver sustainable innovation alongside our customers. We're encouraged by the momentum we're building, and the role sustainability plays in supporting durable, profitable growth."Throughout 2025, DuPont collaborated with customers to introduce sustainably advantaged products, made substantial progress on improving energy efficiency at our sites, reduced our climate impacts, and extended our sustainability expectations into our supply chain. Key Highlights from the 2026 Sustainability Report include:Over 35% of revenue generated from products introduced in the past five years, and nearly 80% of DuPont's active innovation portfolio is expected to deliver sustainable advantages for customers.Achieved a 76% reduction in Scope 1 and 2 greenhouse gas emissions from a 2019 baseline and a 66% reduction in Scope 3 emissions from a 2020 baseline. On track to net-zero emissions by 2050.Approximately 50% of electricity used across DuPont operations is renewably sourced, including 100% of manufacturing operations in Europe. 78% of sites worldwide have implemented 4R programs, designed to minimize waste and maximize resource efficiency.Achieved its safest year on record, surpassing safety performance milestones set in prior years, with 88% of sites with zero recordable injuries or illnesses.DuPont also expanded its sustainability commitment with the introduction of its 2035 Goals focused on sustainable innovation, resilient operations, and people, partners and communities—all grounded in strong governance. The goals set clear priorities across DuPont's organization, operations and value chain, and are designed to strengthen competitiveness, align with customer and market expectations, and support long-term value creation.The 2026 Sustainability Report was developed with reference to the Global Reporting Initiative (GRI) standards, the Sustainability Accounting Standards Board (SASB) standards, and the recommendations outlined by the Task Force on Climate-Related Financial Disclosures (TCFD).To learn more, download and read the full 2026 Sustainability Report at dupont.com/sustainability.About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ? or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.Cautionary Statement about Forward Looking Statements Certain statements in this release may be considered forward-looking statements, within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements often contain words such as "expect", "anticipate", "intend", "plan", "believe", "seek", "see", "will", "would", "target", "outlook", "stabilization", "confident", "preliminary", "initial", "continue", "may", "could", "project", "estimate", "forecast" and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements. Forward-looking statements are not guarantees of future results. Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements.Forward-looking statements include statements which relate to the purpose, ambitions, commitments, targets, plans, objectives, and results of DuPont's sustainability strategy, including its activities related to substances of concern. They include statements related to the standards and measurement of progress against the company's sustainability goals, including metrics, data and other information, which are based on estimates and assumptions believed to be reasonable at the time. The actual conduct of the company's activities and results thereof, including the development, implementation, achievement or continuation of any goal, program, policy or initiative discussed or expected in connection with DuPont's sustainability strategy may differ materially from the statements made herein. The use of the word "material" for the purposes of statements regarding our sustainability strategy and goals should not be read as equating to any use of the word in the company's other disclosures or filings with the U.S. Securities and Exchange Commission (the "SEC").See DuPont's most recent annual report on Form 10-K and subsequent current and periodic reports filed with the SEC for further description of risk factors that could impact the expectations or estimates implied by the Company's forward-looking statements. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.



View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-publishes-2026-sustainability-report-302760231.htmlSOURCE DuPont

Original: DuPont Publishes 2026 Sustainability Report

DuPont Collaborates with Uncountable to Advance AI-Ready Labs StrategyApril 30, 2026 9:00 AM
PR Newswire (US)

WILMINGTON, Del., April 30, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced a strategic collaboration with Uncountable, an AI-driven platform for end-to-end product and application development, to advance its AI-ready labs initiative. The collaboration marks a major step forward in how DuPont scales digital lab workflows, expands access to high-quality experimental data, and turns insights into faster, more efficient innovation across its R&D organization helping customers bring solutions to market with greater speed, consistency, and confidence.







"High-quality, structured data is critical to achieving innovation excellence at scale—enabling advanced analytics, machine learning, and AI to accelerate delivery of solutions to our customers," said Marty DeGroot, Chief Technology Officer at DuPont. "Working with Uncountable strengthens our ability to deploy these capabilities consistently across the enterprise, improving speed to market, R&D effectiveness, and the long-term performance of our innovation portfolio."The collaboration enhances how DuPont designs, tests, and optimizes complex formulations, helping accelerate the delivery of new solutions to customers. By standardizing data and optimizing R&D workflows through Uncountable's platform, DuPont aims to increase R&D productivity, and support durable, profitable growth. This reflects DuPont's continued focus on innovation discipline, digital execution, and competitive differentiation."We're excited to collaborate with DuPont as they scale AI-ready lab workflows across their R&D organization," said Will Tashman, Co-Founder & Chief Customer Officer at Uncountable. "By standardizing data and streamlining how experiments are captured and analyzed, we aim to help DuPont move faster from testing to insight—and accelerate delivery of new solutions to customers."About UncountableUncountable is the AI platform for end-to-end product development. It captures, structures, and connects data across the lifecycle to create a unified data layer powering AI-driven innovation, productivity, and risk reduction. Serving more than 150 customers across chemicals, advanced materials, consumer goods, food and agriculture, and pharmaceuticals, Uncountable operates globally. Learn more at uncountable.com.About DuPontDuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ? or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.



View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-collaborates-with-uncountable-to-advance-ai-ready-labs-strategy-302758823.htmlSOURCE DuPont

Original: DuPont Collaborates with Uncountable to Advance AI-Ready Labs Strategy

Corian® Design Introduces 2026 Color Collection, Expanding What Designers Can Achieve with Nature-Inspired SurfacesApril 21, 2026 9:00 AM
PR Newswire (US)

New aesthetics across solid surface and quartz bring movement, warmth, and design flexibility to commercial interiorsWILMINGTON, Del., April 21, 2026 /PRNewswire/ -- Corian® Design introduces its 2026 Color Collection, Nature in Motion, a new range of aesthetics across Corian® Solid Surface and Corian® Quartz. Inspired by the movement and warmth of natural materials, the collection is designed to give architects and designers greater freedom to use nature-inspired surfaces in commercial applications where traditional materials often limit design possibilities.







At the center of the launch is a new Travertine aesthetic in two colors, developed to capture the movement, tonal variation, and layered depth of natural stone. The aesthetic allows designers to achieve the look of travertine in applications where natural stone can restrict design possibilities, including seamless vertical surfaces, integrated elements, and high-use environments.Inspired by the concept of Nature in Motion, the collection reflects a shift toward materials that introduce warmth, visual softness, and a sense of movement into interior spaces. The palette includes flowing patterns, layered neutrals, and rich brown and mocha tones."Designers are looking for materials that allow them to fully realize their vision without compromise," said Condylia Courtney, Global Business Director, Corian® Design. "This collection delivers the warmth and movement designers seek from natural materials, while enabling applications and performance that traditional materials often restrict."The 2026 introduction includes seven new Corian® Solid Surface aesthetics and two new Corian® Quartz colors, expanding the Corian® Design portfolio with complementary materials that support a wide range of applications and design intent.Corian® Solid Surface enables continuous forms, curved geometries, and integrated elements, allowing designers to extend these new aesthetics beyond countertops into vertical surfaces, feature walls, and custom installations or design elements within the space. Corian® Quartz provides depth and pattern for high-traffic surfaces, offering a coordinated palette across material types.Developed to support the ever-growing healthcare, hospitality, food service, and education environments, the new colors are designed to perform under daily use while helping create more welcoming and engaging spaces.Together, the 2026 Color Collection expands what designers can achieve with surface materials — allowing them to bring their vision to life without the constraints that often accompany traditional surfaces.About Corian® Design
Corian® Design is a global organization which creates, manufactures, and markets advanced materials, products, and solutions for interior design and architecture, originating from a foundation of world-class technologies and expertise. Marketed under the Corian® brand and the Make your Space™ tagline, its materials, products, and solutions meet the most demanding requirements in terms of beauty, functionality, and durability. To learn more about Corian® Design: https://www.corian.com.About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ? or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.



View original content to download multimedia:https://www.prnewswire.com/news-releases/corian-design-introduces-2026-color-collection-expanding-what-designers-can-achieve-with-nature-inspired-surfaces-302747668.htmlSOURCE DuPont

Original: Corian® Design Introduces 2026 Color Collection, Expanding What Designers Can Achieve with Nature-Inspired Surfaces

DuPont Wins Two 2026 Edison Awards™April 17, 2026 9:00 AM
PR Newswire (US)

FilmTec™ Fortilife™ XC160UHP receives Silver in Water, Food & Agriculture categoryDuPont™ Tychem® 6000 SFR receives Bronze in Materials Science categoryWILMINGTON, Del., April 17, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that two of its innovative advanced solutions were recognized with the prestigious 2026 Edison Awards™. DuPont received Silver and Bronze honors for technologies that address critical sustainability and safety challenges across industries.







"We're honored that our advanced solutions and technologies are helping customers tackle some of their most pressing challenges, providing improved performance in safety and sustainability," said Marty DeGroot, DuPont Chief Technology Officer. "This recognition reflects our teams' relentless focus on excellence and the power of close customer collaboration—combining deep application expertise with a clear understanding of customer needs to deliver solutions that drive real-world impact today and help build a more resilient, sustainable future."The two DuPont innovations awarded this year include:Silver – The FilmTec™ Fortilife™ XC160UHP element was recognized in the Water, Food & Agriculture category.  FilmTec™ Fortilife™ XC160UHP is designed to concentrate wastewater streams, providing a more efficient and sustainable approach to water reuse and wastewater treatment. With the ability to operate under ultra-high-pressure conditions, FilmTec™ Fortilife™ XC160UHP elements provide high water recovery to support industrial users facing stringent discharge regulations while helping to reduce energy consumption, carbon emissions, and operational costs compared to conventional method in the market today.It is well-suited for applications requiring sustainable water reuse, such as in the steel and iron industries, power generation, pulp and paper production, and textiles, as well as lithium-ion battery production. Bronze – DuPont™ Tychem® 6000 SFR was recognized in the Materials Science category. Designed to be worn over primary flame-resistant protective clothing, Tychem® 6000 SFR garments help to protect workers in chemical and industrial environments facing both chemical splash and flash fire hazards. Tychem® 6000 SFR fabric provides at least 30 minutes of protection for more than 250 chemical challenges including chemical warfare agents, toxic industrial chemicals, and flammable organic solvents. Unlike traditional chemical protective clothing, in the event that a flash fire occurs, Tychem® 6000 SFR garments won't contribute to additional burn injury if appropriate primary flame-resistant personal protective equipment is worn beneath.Established in 1987, the awards honor excellence in innovation, celebrating the products, services, and leaders transforming how we live and work. Inspired by Thomas Edison's legacy, the program recognizes game-changing solutions across industries worldwide, offering global recognition, credibility, and connections that drive growth. Additional information on the Edison Awards is at www.edisonawards.com.About DuPontDuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ? or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.  



View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-wins-two-2026-edison-awards-302745560.htmlSOURCE DuPont

Original: DuPont Wins Two 2026 Edison Awards™

DuPont Schedules First Quarter 2026 Earnings Conference CallApril 16, 2026 7:00 AM
PR Newswire (US)

WILMINGTON, Del., April 16, 2026 /PRNewswire/ -- DuPont (NYSE: DD) will release its first quarter 2026 financial results at 6:00 a.m. ET on Tuesday, May 5, 2026. In addition, the company will host a conference call at 8:00 a.m. ET that day.







The event will be webcast live and can be accessed on DuPont's Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website.      The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5994046.About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.DuPont™ and all products, unless otherwise noted, denoted with ™, SM or ® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc. 



View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-schedules-first-quarter-2026-earnings-conference-call-302744093.htmlSOURCE DuPont

Original: DuPont Schedules First Quarter 2026 Earnings Conference Call

DuPont Announces Regularly Quarterly Dividend on Common StockApril 15, 2026 4:30 PM
PR Newswire (US)

WILMINGTON, Del., April 15, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Board of Directors has declared a quarterly dividend of twenty cents ($0.20) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on May 29, 2026, to holders of record of said stock at the close of business on May 15, 2026.







About DuPontDuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.DuPont™ and all products, unless otherwise noted, denoted with TM, SM or ® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc.



View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-announces-regularly-quarterly-dividend-on-common-stock-302743510.htmlSOURCE DuPont

Original: DuPont Announces Regularly Quarterly Dividend on Common Stock

$DD Silver’s Industrial Supercycle: Why Demand Is Surging and the World’s Biggest Tech Suppliers Can’t Get Enough
Silver is no longer just a precious metal—it has become the indispensable backbone of the modern electronics economy. As the world electrifies, digitizes, and accelerates into an AI-powered future, silver demand is hitting levels that the mining industry simply cannot keep up with. And the companies consuming the most silver today are not jewelers or investors—they are the industrial giants powering global technology.

The bullish case for silver has never been stronger.

1. Industrial Demand Is Exploding—And Electronics Lead the Charge
Electronics manufacturing consumed 445 million ounces of silver in 2023, making it the single largest industrial driver of silver demand. This is not a cyclical trend—it’s structural.

Every modern device depends on silver because no other metal on Earth conducts electricity better. As electronics shrink and performance requirements rise, silver becomes even more essential.

Silver is everywhere:
Smartphones: 200–300 mg

Laptops/tablets: ~750 mg

TVs: 1–2 g

Gaming consoles: 2–3 g

Servers & AI hardware: even higher concentrations

With billions of devices produced annually, the math is simple: silver demand is locked in and accelerating.

China—responsible for 70% of global electronics production—is a massive demand engine, and its output continues to grow.

2. The Real Silver Super-Users: Industrial Giants You Don’t See on the Device Label
While Apple, Samsung, Sony, Dell, HP, and Lenovo indirectly consume enormous amounts of silver, the direct industrial users are the companies producing the conductive materials that make modern electronics possible.

These companies are quietly driving a silver consumption boom:

🏭 DuPont de Nemours, Inc.
Produces high-purity silver powders, conductive inks, and pastes.

Supplies PCBs, semiconductor packaging, and solar cells.

A foundational supplier for global electronics manufacturing.

🏭 Heraeus Electronics
One of the world’s largest precious-metal technology firms.

Manufactures silver powders, inks, and sintering pastes.

Critical supplier for semiconductors, sensors, and power electronics.

🏭 Electroninks
Produces metal-complex silver inks with up to 90% of bulk silver conductivity.

Used in semiconductor packaging, wearables, medical devices, and PCBs.

A next-generation materials company replacing older silver pastes.

These firms are not just using silver—they are scaling their consumption as electronics become more complex and more miniaturized.

3. Why Silver Is Irreplaceable in the Electrified World
Silver’s unique properties make it the ultimate industrial metal:

Highest electrical conductivity of any metal

Superior thermal conductivity

Reliability in ultra-miniaturized circuits

Resistance to oxidation (unlike copper)

Critical for 5G, AI chips, EVs, and solar

Copper and aluminum cannot match silver’s performance in high-precision electronics. Substitution is not realistic in the sectors that matter most.

As technology advances, silver intensity per device is rising, not falling.

4. Silver Demand Is Broadening Across High-Growth Sectors
Semiconductor Packaging
Silver pastes, inks, and sintering materials are essential for chip bonding and heat dissipation.

Printed Circuit Boards (PCBs)
Silver inks and films form the conductive pathways that power every device.

Switches & Connectors
Silver membrane switches appear in:

Appliances

Toys

Keyboards

Telecom equipment

Every switch, every connector, every circuit is another incremental draw on global silver supply.

5. The Supply Side Can’t Keep Up
Here’s the kicker: silver mine supply is flat to declining, while industrial demand is hitting all-time highs.

Electronics, solar, EVs, and AI hardware are all competing for the same finite pool of silver.

This is the classic setup for a structural deficit—and silver has already been in deficit for multiple consecutive years.

6. The Bullish Thesis in One Line
Silver is the most essential industrial metal of the 21st century, and the companies driving global technology are consuming it faster than the world can mine it.

That’s the core of the bull case.

Arclin Completes Acquisition of the DuPont™ Aramids Business, Including Iconic Kevlar® and Nomex® BrandsApril 1, 2026 1:19 PM
PR Newswire (US)

ALPHARETTA, Ga., April 1, 2026 /PRNewswire/ -- Arclin, a global materials science company, today announced that it has completed the acquisition of DuPont's Aramids business, including the renowned Kevlar® and Nomex® brands, for approximately $1.8 billion. The transaction marks a transformational milestone for Arclin, significantly expanding its scale, capabilities, and presence across life-critical industries. Arclin is a portfolio company of an affiliate of TJC, L.P.
"Kevlar® and Nomex® are the gold standard in their respective industries, and we are very excited to incorporate the Aramids platform into Arclin's broader material science portfolio. This acquisition strategically strengthens Arclin's operational and geographic footprint," said Mark Glaspey, Arclin's President. "With established manufacturing operations in Europe and Asia and ~1,800 new team members around the world, we are focused on operational continuity from day one while investing in manufacturing capabilities and innovation to support long-term growth."With the addition of the Aramids brands, Arclin's portfolio now spans aerospace, electrical infrastructure, electric vehicles, and personal protection and defense. The acquisition further strengthens Arclin's leadership across construction, infrastructure, transportation, and weather and fire protection as demand for advanced protective materials continues to grow. Arclin's proprietary materials and technologies are mission-critical, supporting products that protect people, communities, and essential infrastructure worldwide."We're excited to join the Arclin family and continue advancing the renowned performance that customers have relied on from Kevlar® and Nomex® for decades," said Matt Reinhardt, Business Unit President for Aramids. "Our team's deep expertise in aramid fiber technology, combined with Arclin's commitment to investing in innovation and growth, positions us to better serve our customers and accelerate the development of next-generation protective solutions across industries.""Looking ahead, our mission is to build on the superior strength of the Aramids brands," said Bradley Bolduc, Arclin's Chief Executive Officer. "We're focused on accelerating what these materials can do, putting meaningful investment behind technological innovation and deploying Kevlar® and Nomex® strategically across the world's most performance-critical applications."Piper Sandler & Company served as financial advisor and Kirkland & Ellis LLP served as legal counsel to Arclin and TJC. Centerview Partners and Goldman Sachs & Co. LLC served as DuPont's financial advisors and Skadden, Arps, Slate, Meagher & Flom LLP served as legal counsel.About Arclin
Arclin is a leading materials science company and manufacturer of polymer technologies, engineered products, and specialized materials for the construction, agriculture, transportation infrastructure, weather & fire protection, pharmaceutical, nutrition, electronics, design, and other industries. Headquartered in Alpharetta, Georgia, Arclin has offices and manufacturing facilities across North & South America, Europe, and Asia and serves customers worldwide. For more information, visit www.arclin.com.About TJC
TJC, L.P., formerly known as The Jordan Company, has worked for more than 40 years with CEOs, founders and entrepreneurs across a range of industries including Consumer, Diversified Industrials, Healthcare, Industrial Technology, Logistics & Business Services and Digital & Power Infrastructure. With $30.9 billion of assets under management as of September 30, 2025, TJC is managed by a senior leadership team that has invested together for over 24 years on over 90 investments. TJC has offices in New York, Chicago, Miami and Stamford. For more information, please visit www.tjclp.com.About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.Arclin Media Contact
Jana Wright
Chief Marketing & Communications Officer
inquiries@arclin.com Kevlar® and Nomex® are registered trademarks of Arclin. DuPont™ is a trademark of affiliates of DuPont de Nemours, Inc.Photo - https://mma.prnewswire.com/media/2947568/Arclin_Acquisition_FINAL.jpg 
Logo - https://mma.prnewswire.com/media/2848345/5895470/UPDATED_Arclin_Logo.jpg 



View original content:https://www.prnewswire.co.uk/news-releases/arclin-completes-acquisition-of-the-dupont-aramids-business-including-iconic-kevlar-and-nomex-brands-302731703.html

Original: Arclin Completes Acquisition of the DuPont™ Aramids Business, Including Iconic Kevlar® and Nomex® Brands

Arclin Completes Acquisition of the DuPont™ Aramids Business, Including Iconic Kevlar® and Nomex® BrandsApril 1, 2026 7:45 AM
PR Newswire (US)

ALPHARETTA, Ga., April 1, 2026 /PRNewswire/ -- Arclin, a global materials science company, today announced that it has completed the acquisition of DuPont's Aramids business, including the renowned Kevlar® and Nomex® brands, for approximately $1.8 billion. The transaction marks a transformational milestone for Arclin, significantly expanding its scale, capabilities, and presence across life-critical industries. Arclin is a portfolio company of an affiliate of TJC, L.P.







Arclin Completes Acquisition of the DuPont™ Aramids Business, Including Iconic Kevlar® and Nomex® Brands"Kevlar® and Nomex® are the gold standard in their respective industries, and we are very excited to incorporate the Aramids platform into Arclin's broader material science portfolio. This acquisition strategically strengthens Arclin's operational and geographic footprint," said Mark Glaspey, Arclin's President. "With established manufacturing operations in Europe and Asia and ~1,800 new team members around the world, we are focused on operational continuity from day one while investing in manufacturing capabilities and innovation to support long-term growth."With the addition of the Aramids brands, Arclin's portfolio now spans aerospace, electrical infrastructure, electric vehicles, and personal protection and defense. The acquisition further strengthens Arclin's leadership across construction, infrastructure, transportation, and weather and fire protection as demand for advanced protective materials continues to grow. Arclin's proprietary materials and technologies are mission-critical, supporting products that protect people, communities, and essential infrastructure worldwide."We're excited to join the Arclin family and continue advancing the renowned performance that customers have relied on from Kevlar® and Nomex® for decades," said Matt Reinhardt, Business Unit President for Aramids. "Our team's deep expertise in aramid fiber technology, combined with Arclin's commitment to investing in innovation and growth, positions us to better serve our customers and accelerate the development of next-generation protective solutions across industries.""Looking ahead, our mission is to build on the superior strength of the Aramids brands," said Bradley Bolduc, Arclin's Chief Executive Officer. "We're focused on accelerating what these materials can do, putting meaningful investment behind technological innovation and deploying Kevlar® and Nomex® strategically across the world's most performance-critical applications."Piper Sandler & Company served as financial advisor and Kirkland & Ellis LLP served as legal counsel to Arclin and TJC. Centerview Partners and Goldman Sachs & Co. LLC served as DuPont's financial advisors and Skadden, Arps, Slate, Meagher & Flom LLP served as legal counsel.About Arclin
Arclin is a leading materials science company and manufacturer of polymer technologies, engineered products, and specialized materials for the construction, agriculture, transportation infrastructure, weather & fire protection, pharmaceutical, nutrition, electronics, design, and other industries. Headquartered in Alpharetta, Georgia, Arclin has offices and manufacturing facilities across North & South America, Europe, and Asia and serves customers worldwide. For more information, visit www.arclin.com.About TJC
TJC, L.P., formerly known as The Jordan Company, has worked for more than 40 years with CEOs, founders and entrepreneurs across a range of industries including Consumer, Diversified Industrials, Healthcare, Industrial Technology, Logistics & Business Services and Digital & Power Infrastructure. With $30.9 billion of assets under management as of September 30, 2025, TJC is managed by a senior leadership team that has invested together for over 24 years on over 90 investments. TJC has offices in New York, Chicago, Miami and Stamford. For more information, please visit www.tjclp.com.About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.Arclin Media Contact
Jana Wright
Chief Marketing & Communications Officer
inquiries@arclin.com Kevlar® and Nomex® are registered trademarks of Arclin. DuPont™ is a trademark of affiliates of DuPont de Nemours, Inc.










View original content to download multimedia:https://www.prnewswire.com/news-releases/arclin-completes-acquisition-of-the-dupont-aramids-business-including-iconic-kevlar-and-nomex-brands-302731290.htmlSOURCE Arclin

Original: Arclin Completes Acquisition of the DuPont™ Aramids Business, Including Iconic Kevlar® and Nomex® Brands

DuPont Completes Divestiture of Aramids BusinessApril 1, 2026 7:32 AM
PR Newswire (US)

WILMINGTON, Del., April 1, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has completed the previously-announced divestiture of its Aramids business (Kevlar® and Nomex®) to Arclin, a portfolio company of an affiliate of TJC, L.P. (TJC), in a transaction valuing the business at approximately $1.8 billion.







With the close of the transaction, DuPont receives pre-tax cash proceeds of approximately $1.2 billion, subject to customary transaction adjustments, a note receivable of $300 million, and a non-controlling common equity interest in Arclin currently valued at $325 million, which is expected to represent an approximate 16% stake.The results of the Aramids business were reclassified and reported as discontinued operations beginning in third quarter 2025 for current and historical periods.About Arclin
Arclin is a leading materials science company and manufacturer of polymer technologies, engineered products, and specialized materials for the construction, agriculture, transportation infrastructure, weather & fire protection, pharmaceutical, nutrition, electronics, design, and other industries. Headquartered in Alpharetta, Georgia, Arclin has offices and manufacturing facilities across North & South America, Europe, and Asia and serves customers worldwide. For more information, visit www.arclin.com.About TJC
TJC, L.P., formerly known as The Jordan Company, has worked for more than 40 years with CEOs, founders and entrepreneurs across a range of industries including Consumer, Diversified Industrials, Healthcare, Industrial Technology, Logistics & Business Services and Digital & Power Infrastructure. With $30.9 billion of assets under management as of September 30, 2025, TJC is managed by a senior leadership team that has invested together for over 24 years on over 90 investments. TJC has offices in New York, Chicago, Miami and Stamford. For more information, please visit www.tjclp.com.About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ? or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.Cautionary Statement Regarding Forward-Looking StatementsThis communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target, "outlook," "stabilization," "confident," "preliminary," "initial," and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements, including statements regarding outlook, expectations and guidance.  Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements.Forward-looking statements are not guarantees of future results. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. 



View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-completes-divestiture-of-aramids-business-302731294.htmlSOURCE DuPont

Original: DuPont Completes Divestiture of Aramids Business

DuPont Contributes Water Treatment Technologies and Expertise to Increase Water Access in KenyaMarch 30, 2026 9:00 AM
PR Newswire (US)

New Water Plant in Baringo, Kenya is Latest Collaboration with ChildFund and OthersWILMINGTON, Del., March 30, 2026 /PRNewswire/ -- Aligned with World Water Day 2026, DuPont (NYSE: DD) celebrated the commissioning of a new multi-tech water treatment plant in Baringo, Kenya, giving families in the rural community of Kampi Ya Samaki their first reliable source of clean and healthy drinking water.







Delivered through its long-running partnership with the international charity ChildFund, this new water treatment plant uses donated DuPont™ IntegraTec™ ultrafiltration modules and DuPont™ FilmTec™ reverse osmosis elements, along with technical expertise, to removes fluoride and other contaminants and produce a reliable source potable water.Previously, the community's residents relied on untreated water from Lake Baringo for drinking. For decades, fluoride concentrations in the lake have exceeded World Health Organization (WHO) safety limits, creating a serious public health risk across generations; residents report widespread dental fluorosis and an elevated risk of skeletal fluorosis. In addition to directly serving Kampi Ya Samaki, the project is expected to benefit up to 20,000 people through an expanded distribution network supplying 1,500 households, three schools, and a health facility.The Kampi Ya Samaki project has been delivered in collaboration with the County Government of Baringo, the Central Rift Valley Water Works Development Agency, Davis & Shirtliff, Hand in Hand Eastern Africa, and the Central Rift Community Development Program—allowing for alignment with public health priorities and long-term water planning.Together, DuPont Water Solutions, ChildFund, and other supporters have developed scalable solutions to deliver safe, reliable sources of drinking water for communities in Kenya and Zambia. The projects utilize DuPont purification technology to reduce irons bacteria, turbidity, and color in local water sources through sustainable community-led efforts."Our collaboration with ChildFund shows what's possible when advanced water treatment technologies are paired with deep technical expertise—and applied with purpose," said Alex Lane, Regional Commercial Director for DuPont Water Solutions in Europe, Middle East, and Africa. "We're proud to continue our work with ChildFund bringing our water treatment expertise to projects that deliver lasting community benefit. Working side-by-side, we can design and deploy solutions that are robust, locally appropriate, and built to endure.""Beyond delivering safe drinking water, the project is expected to unlock broad social and economic gains—from better health outcomes and reduced medical costs to stronger school attendance—especially for women and girls," said Alex Mucheru, who led this project for DuPont Water Solutions. "Together with ChildFund, we are deploying proven purification technologies that are robust, scalable, and right-sized for the communities they serve. This project delivers a replicable approach that can be deployed quickly to help more communities gain access to clean, healthy drinking water.""Partnering is central to delivering solutions at this scale," said Erin Kennedy of ChildFund. "In Baringo, we are seeing what coordinated investment and shared expertise can achieve, turning a long-standing public health challenge into a practical, community-driven solution that will serve families for years to come."DuPont Water Solutions technologies are helping to purify more than 50 million gallons of water every minute in 112 countries across the world. To learn more about how DuPont Water Solutions' portfolio of water purification and separation technologies are helping communities overcome water and wastewater challenges, visit: http://www.dupont.com/water.htmlAbout DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ? or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.



View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-contributes-water-treatment-technologies-and-expertise-to-increase-water-access-in-kenya-302727791.htmlSOURCE DuPont

Original: DuPont Contributes Water Treatment Technologies and Expertise to Increase Water Access in Kenya

/C O R R E C T I O N -- DuPont/March 18, 2026 5:08 PM
PR Newswire (US)

In the news release, DuPont Announces Plans for Reverse Stock Split, issued March 18, 2026 by DuPont over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:
DuPont Announces Plans for Reverse Stock Split
WILMINGTON, Del., March 18, 2026 /PRNewswire/ -- DuPont (NYSE:DD) announced today that it plans to seek stockholder approval for an amendment to the Company's Certificate of Incorporation to effect, at the discretion of the Board of Directors, a reverse stock split of the Company's common stock at a ratio of not less than 1-for-2 or more than 1-for-4, with the exact ratio to be determined by the Board of Directors at a later date. If and when the reverse stock split is effected, the Certificate of Incorporation will also be amended to reflect a corresponding reduction in the number of authorized shares of the Company's common stock by the selected reverse stock split ratio. The reverse stock split will have no impact on the voting and other rights of stockholders and will have no impact on the Company's business operations or any of its outstanding indebtedness.







DuPont will seek approval of the reverse stock split at its Annual Meeting of Stockholders on May 21, 2026. DuPont's Board of Directors has set March 30, 2026, as the record date for stockholders entitled to vote at the Annual Meeting. The time and other details regarding the Annual Meeting will be communicated to stockholders at a later date via proxy materials which will be filed with, and will be subject to review by, the U.S. Securities and Exchange Commission (the "SEC").Even if the reverse stock split is approved by the Company's stockholders, the Board of Directors may delay or abandon the reverse stock split at any time prior to the effective time of the reverse stock split if the Board of Directors determines that the reverse stock split is no longer in the best interests of the Company or its stockholders.Solicitation Material
This communication may be deemed to be solicitation material in connection with the proposal to be submitted to DuPont's stockholders at its Annual Meeting of Stockholders seeking approval of an amendment to the Certificate of Incorporation to effect a reverse stock split. In connection with the proposal, DuPont plans to file a preliminary proxy statement on Schedule 14A with the SEC. The Company expects to file its definitive proxy material in due course. Stockholders are encouraged to read the preliminary proxy statement and all other relevant documents filed with the SEC when they become available, including the definitive proxy statement, because they will contain important information about the proposal. Stockholders may obtain a free copy of the proxy statement and other documents that the Company files with the SEC at the SEC's website (www.sec.gov) or from the Company by accessing information included on the Investor Relations website (investors.dupont.com).About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.Cautionary Statement Regarding Forward-Looking InformationCertain statements in this release may be considered forward-looking statements, within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements often contain words such as "expect", "anticipate", "intend", "plan", "believe", "seek", "see", "will", "would", "target", "outlook", "stabilization", "confident", "preliminary", "initial", "continue", "may", "could", "project", "estimate", "forecast" and similar expressions and variations or negatives of these words . All statements, other than statements of historical fact, are forward-looking statements and include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, the timing, ratio, completion, and benefits of the reverse stock split. Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements. Additional information concerning the risks, uncertainties and assumptions can be found in DuPont's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2025, subsequent quarterly reports on Form 10-Q and other filings. Forward-looking statements are not guarantees of future results. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ? or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.Correction: An earlier version of this release had an incorrect date in the second paragraph.



View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-announces-plans-for-reverse-stock-split-302717978.htmlSOURCE DuPont

Original: /C O R R E C T I O N -- DuPont/

DuPont Announces Plans for Reverse Stock SplitMarch 18, 2026 4:30 PM
PR Newswire (US)

WILMINGTON, Del., March 18, 2026 /PRNewswire/ -- DuPont (NYSE:DD) announced today that it plans to seek stockholder approval for an amendment to the Company's Certificate of Incorporation to effect, at the discretion of the Board of Directors, a reverse stock split of the Company's common stock at a ratio of not less than 1-for-2 or more than 1-for-4, with the exact ratio to be determined by the Board of Directors at a later date. If and when the reverse stock split is effected, the Certificate of Incorporation will also be amended to reflect a corresponding reduction in the number of authorized shares of the Company's common stock by the selected reverse stock split ratio. The reverse stock split will have no impact on the voting and other rights of stockholders and will have no impact on the Company's business operations or any of its outstanding indebtedness.







DuPont will seek approval of the reverse stock split at its Annual Meeting of Stockholders on May 21, 2026. DuPont's Board of Directors has set March 18, 2026, as the record date for stockholders entitled to vote at the Annual Meeting. The time and other details regarding the Annual Meeting will be communicated to stockholders at a later date via proxy materials which will be filed with, and will be subject to review by, the U.S. Securities and Exchange Commission (the "SEC").Even if the reverse stock split is approved by the Company's stockholders, the Board of Directors may delay or abandon the reverse stock split at any time prior to the effective time of the reverse stock split if the Board of Directors determines that the reverse stock split is no longer in the best interests of the Company or its stockholders.Solicitation Material
This communication may be deemed to be solicitation material in connection with the proposal to be submitted to DuPont's stockholders at its Annual Meeting of Stockholders seeking approval of an amendment to the Certificate of Incorporation to effect a reverse stock split. In connection with the proposal, DuPont plans to file a preliminary proxy statement on Schedule 14A with the SEC. The Company expects to file its definitive proxy material in due course. Stockholders are encouraged to read the preliminary proxy statement and all other relevant documents filed with the SEC when they become available, including the definitive proxy statement, because they will contain important information about the proposal. Stockholders may obtain a free copy of the proxy statement and other documents that the Company files with the SEC at the SEC's website (www.sec.gov) or from the Company by accessing information included on the Investor Relations website (investors.dupont.com).About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.Cautionary Statement Regarding Forward-Looking InformationCertain statements in this release may be considered forward-looking statements, within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements often contain words such as "expect", "anticipate", "intend", "plan", "believe", "seek", "see", "will", "would", "target", "outlook", "stabilization", "confident", "preliminary", "initial", "continue", "may", "could", "project", "estimate", "forecast" and similar expressions and variations or negatives of these words . All statements, other than statements of historical fact, are forward-looking statements and include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, the timing, ratio, completion, and benefits of the reverse stock split. Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements. Additional information concerning the risks, uncertainties and assumptions can be found in DuPont's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2025, subsequent quarterly reports on Form 10-Q and other filings. Forward-looking statements are not guarantees of future results. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ? or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.



View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-announces-plans-for-reverse-stock-split-302717978.htmlSOURCE DuPont

Original: DuPont Announces Plans for Reverse Stock Split

Kevlar® and Nomex® Sponsor Military Appreciation at THE 2026 PLAYERS ChampionshipMarch 10, 2026 8:00 AM
PR Newswire (US)

Attendees will also have the chance to experience first-hand Kevlar EXO's collaboration with golf shaft designer, KINETIXXRICHMOND, Va., March 10, 2026 /PRNewswire/ -- Kevlar® and Nomex®, long-standing supporters of military appreciation initiatives, are proud to announce their sponsorship of the Military Appreciation tickets and the Patriots' Outpost at THE 2026 PLAYERS Championship. This commitment demonstrates the enduring dedication of both Kevlar® and Nomex® to the veteran community, providing a unique experience at one of the PGA's premier events.







"Our team is looking forward to a fantastic week at THE PLAYERS. We're excited to welcome members of the armed forces and veterans to relax and watch the world's best golfers compete at the PLAYERS Championship," said Matthew Yakush, Global Market Development Leader Kevlar® EXO™. "This sponsorship was a natural fit as part of our commitment to improving and protecting the lives of the members of our military."Honoring Service Members at THE PLAYERSAs part of their sponsorship, Kevlar® and Nomex® are providing tickets for veterans to attend the event and special access to the Patriots' Outpost hospitality tent. Located adjacent to the 16th tee/fairway, the Outpost offers military members, veterans, and their families exclusive views, a dedicated space for camaraderie, and complimentary snacks and beverages, recognizing and celebrating the contributions of our service members.Military attendees at THE PLAYERS, held from March 10-15, 2026, at TPC Sawgrass in Ponte Vedra Beach, FL, will also have the opportunity to learn more about Kevlar® and Nomex® offerings such as new body armor from Point Blank Enterprises, Nomex® flight jackets and gloves, and experience the new KINETIXX and Kevlar® EXO™ collaboration. This partnership launched KINETIXX's SyrgeX and FlexurX golf shaft platforms in February, which are designed to leverage Kevlar® EXO™'s innovation for enhanced mechanical efficiency and refined tactile response.Advancements in Material ScienceThe KINETIXX and Kevlar® EXO™ golf shaft collaboration showcases the advanced properties of Kevlar® EXO™, a next-generation aramid fiber. The expansion to golf follows approval for use cases across ballistics protection, flexible fuel bladders, orbital debris shielding, and aerospace deployable structures. Kevlar® EXO™ is engineered to deliver high levels of strength, flexibility, durability, and flame resistance while optimizing material usage and weight. Nomex® is an inherently heat and flame-resistant fiber that does not melt, drip, or support combustion, providing a superior barrier against hazards. These materials exemplify innovation in performance and protection.For more information please visit https://www.dupont.com/brands/kevlar.html and https://www.dupont.com/brands/nomex.htmlAbout DuPontDuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and transportation. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.Contact: KevlarEXO@nextpr.com



View original content to download multimedia:https://www.prnewswire.com/news-releases/kevlar-and-nomex-sponsor-military-appreciation-at-the-2026-players-championship-302708488.htmlSOURCE DuPont Kevlar® EXO™

Original: Kevlar® and Nomex® Sponsor Military Appreciation at THE 2026 PLAYERS Championship

DuPont Announces Regular Quarterly Dividend on Common StockFebruary 19, 2026 5:22 PM
PR Newswire (US)

WILMINGTON, Del., Feb. 19, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Board of Directors has declared a quarterly dividend of twenty cents ($0.20) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on March 16, 2026, to holders of record of said stock at the close of business on March 2, 2026.







About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ? or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.



View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-announces-regular-quarterly-dividend-on-common-stock-302693135.htmlSOURCE DuPont

Original: DuPont Announces Regular Quarterly Dividend on Common Stock

DuPont edges past Q4 profit forecasts and sets guidance for the year aheadFebruary 10, 2026 8:25 AM
IH Market News
DuPont De Nemours Inc (NYSE:DD) reported fourth-quarter results on Tuesday that slightly exceeded analyst expectations on earnings, while revenue broadly matched forecasts.The industrial group delivered earnings per share of $0.46 for the quarter, beating the consensus estimate of $0.43. Revenue reached $1.7 billion, essentially in line with market expectations of $1.69 billion.DuPont said organic sales declined 1% year on year, reflecting a $30 million, or 2%, headwind linked to a timing shift from the third quarter. Despite the softer organic performance, operating EBITDA increased 4% to $409 million.Looking ahead, the company said it expects first-quarter fiscal 2026 earnings per share of around $0.48, with sales of approximately $1.67 billion and operating EBITDA of about $395 million.For the full 2026 financial year, DuPont forecast earnings per share in a range of $2.25 to $2.30, alongside revenue of $7.08 billion to $7.14 billion. Operating EBITDA for the year is projected to come in between $1.72 billion and $1.75 billion.DuPont de Nemours stock price

Original: DuPont edges past Q4 profit forecasts and sets guidance for the year ahead

DuPont Reports Fourth Quarter and Full Year 2025 ResultsFebruary 10, 2026 6:00 AM
PR Newswire (US)

Exceeds Fourth Quarter and Full Year 2025 Guidance 
Initiates First Quarter and Full Year 2026 Guidance Fourth Quarter 2025 HighlightsNet Sales of $1.7 billion were flat; organic sales decreased 1% versus year-ago period including a $30 million, or 2%, headwind from the third quarter timing shiftGAAP Loss from continuing operations of $(108) million; operating EBITDA of $409 millionGAAP EPS from continuing operations of $(0.27); adjusted EPS of $0.46Cash provided by operating activities from continuing operations of $87 million, including $228 million of separation-related transaction cost and other payments; transaction-adjusted free cash flow of $228 millionFull Year 2025 HighlightsNet Sales of $6.8 billion increased 2%; organic sales increased 2% versus year-ago periodGAAP Income from continuing operations of $98 million; operating EBITDA of $1.63 billionGAAP EPS from continuing operations of $0.21; adjusted EPS of $1.68Cash provided by operating activities from continuing operations of $560 million, including $462 million of separation-related transaction cost and other payments; transaction-adjusted free cash flow of $689 millionWILMINGTON, Del., Feb. 10, 2026 /PRNewswire/ -- DuPont (NYSE: DD) announced its financial results(1) for the fourth quarter and full year ended December 31, 2025 and initiated financial guidance for the first quarter and full year 2026. 







"Our full year results capped a year of strong, disciplined execution" said Lori Koch, DuPont Chief Executive Officer. "Our teams delivered against our commitments in a dynamic macro environment, driving organic growth, margin expansion, double-digit adjusted EPS growth, and strong cash flow generation.""Exiting the year with this momentum, we are well positioned to continue advancing our strategic priorities centered on driving growth and delivering consistent performance to create value for shareholders, customers and our employees," Koch concluded.Fourth Quarter 2025 Consolidated Results(1)
 Dollars in millions, unless noted 4Q'25 4Q'24Changevs. 4Q'24Organic Sales (2)vs. 4Q'24Net sales$1,693$1,689-(1) %GAAP Income from continuing operations$(108)$(291)63 %
Operating EBITDA(2)$409$3954 %
Operating EBITDA margin(2) %24.2 %23.4 %80 bps
GAAP EPS from continuing operations$(0.27)$(0.70)61 %
Adjusted EPS(2)$0.46$0.3918 %
Cash provided by operating activities – cont. ops.$87$161(46) %
Transaction-adjusted free cash flow(2)$228$11992 %
Net salesNet sales were flat as a 1% decrease in volume was offset by a 1% currency benefit. Price was flat year-over-year. Fourth quarter net sales included an approximately $30 million, or 2%, headwind from the order timing shift into the third quarter related to system cut-over activities in advance of the planned electronics separation.3% organic sales growth in Healthcare & Water Technologies; 4% organic sales decline in Diversified Industrials.GAAP Loss from continuing operationsGAAP Loss/GAAP EPS from continuing operations improved on higher segment earnings and the absence of prior year losses related to interest rate swaps.Operating EBITDAOperating EBITDA increased on favorable mix and cost productivity, partially offset by growth investments.Adjusted EPSAdjusted EPS increased on higher segment earnings and lower interest expense, partially offset by a higher tax rate.Cash provided by operating activities from continuing operationsCash provided by operating activities from continuing operations in the quarter of $87 million, capital expenditures of $87 million and separation-related transaction cost and other payments of $228 million resulted in transaction-adjusted free cash flow and related conversion of $228 million and 118%, respectively.(1)Results and cash flows are presented on a continuing operations basis, now reflecting the Electronics and Aramids businesses as discontinued operations. See page 8 for further information, including the basis of presentation included in this release.(2)Organic sales, operating EBITDA, operating EBITDA margin, adjusted EPS, transaction-adjusted free cash flow and transaction-adjusted free cash flow conversion are non-GAAP measures and only reflect continuing operations. See page 9 for further discussion, including a definition of significant items. Reconciliation to the most directly comparable GAAP measure, including details of significant items begins on page 16 of this communication.(3)Effective in the fourth quarter of 2025, following the separation of the Electronics business on November 1, 2025, the Company made changes to its management and reporting structure creating two new reportable segments: Healthcare & Water Technologies and Diversified Industrials.  Fourth Quarter 2025 Segment Highlights
Healthcare & Water Technologies(3) Dollars in millions, unless noted 4Q'25 4Q'24Changevs. 4Q'24Organic Sales(2)vs. 4Q'24Net sales$821$7904 %3 %Operating EBITDA$255$2464 %
Operating EBITDA margin %31.1 %31.1 %-
Net salesNet sales increased 4% on organic sales growth of 3% and a currency benefit of 1%. Fourth quarter net sales included an approximately $15 million, or 2%, headwind from the order timing shift into the third quarter due to separation-related activities primarily in Water Technologies.Healthcare Technologies sales up mid-single digits on an organic basis on broad-based growth led by medical packaging and medical devices.Water Technologies sales up low-single digits on an organic basis primarily due to strength in industrial water markets.Operating EBITDAOperating EBITDA increased on organic growth and productivity, partially offset by growth investments.Operating EBITDA margin of 31.1% was flat year-over-year.Diversified Industrials(3)
 Dollars in millions, unless noted 4Q'25 4Q'24Changevs. 4Q'24Organic Sales(2)vs. 4Q'24Net sales$872$899(3) %(4) %Operating EBITDA$197$1932 %
Operating EBITDA margin %22.6 %21.5 %110 bps
Net salesNet sales decreased 3% as organic sales declines of 4% were partially offset by a 1% benefit from currency. Fourth quarter net sales included an approximately $15 million, or 2%, headwind from the order timing shift into the third quarter due to separation-related activities primarily in Industrial Technologies.Building Technologies sales down high-single digits on an organic basis from ongoing weakness in construction markets.Industrial Technologies sales down low-single digits on an organic basis as strength in aerospace was offset by weakness in printing and packaging markets.Operating EBITDAOperating EBITDA increased on favorable mix and cost productivity.Operating EBITDA margin of 22.6% increased 110 basis points. Full Year 2025 Consolidated Results(1)
 Dollars in millions, unless noted FY'25 FY'24Changevs. FY'24Organic Sales(2)vs. FY'24Net sales$6,849$6,7192 %2 %GAAP Income (loss) from continuing operations$98$(96)202 %
Operating EBITDA(2)$1,628$1,5316 %
Operating EBITDA margin(2) %23.8 %22.8 %100 bps
GAAP EPS from continuing operations$0.21$(0.23)191 %
Adjusted EPS(2)$1.68$1.4516 %
Cash provided by operating activities – cont. ops.$560$765(27) %
Transaction-adjusted free cash flow(2)$689$58717 %
Net salesNet sales increased 2% as a 3% increase in volume was partially offset by a 1% decrease in price.7% organic sales growth in Healthcare & Water Technologies; 2% organic sales decline in Diversified Industrials.GAAP Income from continuing operationsGAAP Income/GAAP EPS from continuing operations increased on higher segment earnings and a lower effective tax rate.Operating EBITDAOperating EBITDA increased on organic growth and productivity, partially offset by growth investments.Adjusted EPSAdjusted EPS increased on higher segment earnings and lower interest expense.Cash provided by operating activities from continuing operationsCash provided by operating activities from continuing operations in the year of $560 million, capital expenditures of $333 million and separation-related transaction cost and other payments of $462 million resulted in transaction-adjusted free cash flow and related conversion of $689 million and 98%, respectively. Full Year 2025 Segment Highlights
Healthcare & Water Technologies(3)
 Dollars in millions, unless noted FY'25 FY'24Changevs. FY'24Organic Sales(2)vs. FY'24Net sales$3,233$2,9769 %7 %Operating EBITDA$972$84415 %
Operating EBITDA margin %30.1 %28.4 %170 bps
Net salesNet sales increased 9% on organic sales growth of 7%, a currency benefit of 1% and a portfolio benefit of 1%.Healthcare Technologies sales up high-single digits on an organic basis on broad-based growth led by medical packaging and biopharma.Water Technologies sales up mid-single digits on an organic basis primarily due to strength in industrial and municipal water markets.Operating EBITDAOperating EBITDA increased on organic growth and productivity, partially offset by growth investments.Operating EBITDA margin of 30.1% increased 170 basis points.Diversified Industrials(3) Dollars in millions, unless noted FY'25 FY'24Changevs. FY'24Organic Sales(2)vs. FY'24Net sales$3,616$3,743(3) %(2) %Operating EBITDA$800$839(5) %
Operating EBITDA margin %22.1 %22.4 %(30) bps
Net salesNet sales decreased 3% on an organic sales decline of 2% and a portfolio headwind of 1%.Building Technologies sales down mid-single digits on an organic basis from ongoing weakness in construction markets.Industrial Technologies sales up low-single digits on an organic basis driven by growth in aerospace markets.Operating EBITDAOperating EBITDA decreased as cost productivity was more than offset by the organic sales decline.Operating EBITDA margin of 22.1% decreased 30 basis points. 2026 Financial Outlook Dollars in millions, unless noted



 1Q'26E  Full Year 2026E Net sales



~$1,670$7,075 - $7,135Operating EBITDA(2)



~$395$1,725 - $1,755Adjusted EPS(2)



~$0.48$2.25 - $2.30"Our fourth quarter and full year results reflect disciplined execution across the company and a continued focus on operational and financial rigor delivering strong cash generation and margin expansion," said Antonella Franzen, DuPont Chief Financial Officer."Our 2026 guidance is in line with the medium-term targets communicated at our recent investor day. Our full year net sales guidance assumes about 3% organic growth and a currency tailwind of about 1% versus last year. Our first quarter net sales assumes about 2% organic growth coupled with a currency tailwind of about 2% on a year-over-year basis," Franzen concluded.Conference CallThe Company will host a live webcast of its quarterly earnings conference call with investors to discuss its results and business outlook beginning today at 8:00 a.m. ET. The slide presentation that accompanies the conference call will be posted on the DuPont's Investor Relations Events and Presentations page. A replay of the webcast also will be available on the DuPont's Investor Relations Events and Presentations page following the live event.About DuPontDuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.DuPont™ and all products, unless otherwise noted, denoted with ™, SM or ® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc.OverviewDuPont de Nemours, Inc. ("DuPont") completed the previously announced separation of its Electronics business (the "Electronics Separation") into an independent public company, Qnity Electronics, Inc. ("Qnity"), by way of the distribution to DuPont's stockholders of record as of October 22, 2025 of all the issued and outstanding common stock of Qnity on November 1, 2025 (the "Qnity Distribution"). As a result, beginning in the fourth quarter of 2025, the financial results of the divested Electronics business are reflected in DuPont's Consolidated Financial Statements as discontinued operations, along with comparative periods.On August 29, 2025, DuPont announced a definitive agreement to sell the aramids business (the "Aramids Divestiture") to Arclin a portfolio company of a TJC LP, ("TJC") affiliate, in return for pre-tax cash proceeds of approximately $1.2 billion, subject to customary transaction adjustments, a note from TJC in the principal amount of $300 million and a minority equity interest (the "Equity Consideration") valued at $325 million in the future Arclin holding company that will hold the Arclin global materials business and the aramids business being divested. The transaction is expected to close around the end of the first quarter 2026, subject to customary closing conditions and receipt of regulatory approvals. As a result, beginning in the third quarter of 2025, the financial results of the aramids business being divested are reflected in DuPont's Consolidated Financial Statements as discontinued operations, along with comparative periods.Cautionary Statement Regarding Forward-looking StatementsCertain statements in this release may be considered forward-looking statements, within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements often contain words such as "expect", "anticipate", "intend", "plan", "believe", "seek", "see", "will", "would", "target", "outlook", "stabilization", "confident", "preliminary", "initial", "continue", "may", "could", "project", "estimate", "forecast" and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements. Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements.Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to (i) the ability to realize the intended benefits of the Electronics Separation and Qnity Distribution, including achievement of the intended tax treatment; contractual allocation to, and assumption by Qnity of certain liabilities, including certain legacy liabilities with respect to PFAS; and the possibility of disputes, litigation or unanticipated costs in connection with the Electronics Separation and Distribution; (ii) the ability to timely effect, if at all, the Aramids Divestiture and the impact on DuPont's balance sheet, financial condition and future results of operations; (iii) risks and costs related to the impact of the arrangement to share future eligible PFAS costs by and among DuPont, Corteva and Chemours, including the outcome of pending or future litigation related to PFAS or PFOA, which includes personal injury claims and natural resource damages claims; the extent and cost of ongoing and potential future remediation obligations; and changes in laws and regulations applicable to PFAS chemicals; (iv) the failure to realize expected benefits and effectively manage and achieve anticipated synergies and operational efficiencies in connection with the Electronics Separation, the Aramids Divestiture and completed and future, if any, divestitures, mergers, acquisitions, and other portfolio management, productivity and infrastructure actions; (v) risks and uncertainties that are outside the Company's control but adversely impact the overall environment in which DuPont, its customers and/or its suppliers operate, including changes in economic, political, regulatory, international trade, geopolitical, military conflicts, capital markets and other external conditions, including pandemics and responsive actions, as well as natural and other disasters or weather-related events; (vi) the ability to offset increases in cost of inputs, including raw materials, energy and logistics; (vii) the risks and uncertainties associated with continuing or expanding trade disputes or restrictions and responsive actions, new or increased tariffs or export controls including on exports to China of U.S.-regulated products and technology; (viii) other risks to DuPont's business and operations, including the risk of impairment; (ix) risks and uncertainties in connection with completing the $2 billion share buyback authorization DuPont announced on November 3, 2025, including timeline, associated costs and the possibility that the authorization may be suspended or discontinued prior to completion; and (x) other risk factors discussed in DuPont's most recent annual report on Form 10-K, and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with the U.S. Securities and Exchange Commission.Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business or supply chain disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont's consolidated financial condition, results of operations, credit rating or liquidity. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.Non-GAAP Financial MeasuresUnless otherwise indicated, all financial metrics presented reflect continuing operations only.This communication includes information that does not conform to accounting principles generally accepted in the United States of America ("U.S. GAAP") and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company, including allocating resources. DuPont's management believes these non-GAAP financial measures are useful to investors because they provide additional information related to the ongoing performance of DuPont to offer a more meaningful comparison related to future results of operations. These non-GAAP financial measures supplement disclosures prepared in accordance with U.S. GAAP, and should not be viewed as an alternative to U.S. GAAP. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Reconciliations for these Non-GAAP measures to U.S. GAAP are provided in the Selected Financial Information and Non-GAAP Measures starting on page 15. Non-GAAP measures included in this communication are defined below. The Company has not provided forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of certain future events. These events include, among others, the impact of portfolio changes, including asset sales, mergers, acquisitions, and divestitures; contingent liabilities related to litigation, environmental and indemnifications matters; impairments and discrete tax items. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.Key TermsSignificant ItemsSignificant items are items that arise outside the ordinary course of business for the Company, and beginning in the first quarter 2025, includes items for nonconsolidated affiliates, that the Company's management believes may cause misinterpretation of underlying business and investment performance, both historical and future, based on a combination of some or all of the item's size, unusual nature and infrequent occurrence. Management classifies as significant items certain costs and expenses associated with integration and separation activities related to transformational acquisitions and divestitures as they are considered unrelated to ongoing business performance. Management believes the update to the definition of significant items to include those related to nonconsolidated affiliates reflects a more accurate measure of the ongoing performance of the investment. There were no significant items associated with nonconsolidated affiliates recorded for the three and twelve month periods ended December 31, 2025 and December 31, 2024.Future Reimbursable Indirect CostsIndirect costs, such as those related to corporate and shared service functions allocated to the separated Electronics business, the divested Delrin® business and the Aramids business, do not meet the criteria for discontinued operations and are reported within continuing operations in all respective periods presented. The Company has, is, will or expects to be reimbursed in accordance with the applicable transition service agreements ("TSAs") for the portion of indirect costs related to activities the Company is, will or expects to undertake on a transitional basis to support a) the divested Delrin® business, b) Qnity not beyond year end 2027 for services and 2040 for site leases and, c) the Aramids Business post the intended Aramids Divestiture, but not beyond 2028 (such indirect costs "Future Reimbursable Indirect Costs"). Services provided and costs reimbursed in accordance with the applicable TSAs include but are not limited to, costs associated with information technology services/support, product stewardship and regulatory support, facilities services, and shared property lease costs.Future Reimbursable Indirect Costs do not meet the criteria for discontinued operations and therefore are included in both GAAP Net Income from Continuing Operations and in GAAP Cash provided by operating activities-continuing operations for all periods presented. Future Reimbursable Indirect Costs are excluded from Adjusted Earnings, Operating EBITDA and beginning in the fourth quarter 2025, from Transaction-Adjusted Free Cash Flow, each defined below. Such indirect costs that are not subject to future reimbursement are reported within continuing operations in Corporate & Other and are included within Adjusted Earnings, Operating EBITDA, and Cash provided by operating activities-continuing operations.Corporate DDOB Remediation CostsCorporate DDOB Remediation Costs are environmental remediation costs, including certain investigate, remediate and restoration costs, associated with discontinued or divested operations, businesses or product lines ("Corporate DDOB Remediation Costs"). Subsequent to the spin-off of Qnity and beginning with the fourth quarter of 2025, DDOB Remediation Costs are excluded from Adjusted Earnings and Operating EBITDA, as defined below, to provide better insight into the underlying business performance of the Company. This update was applied for all periods presented.Non-GAAP Measure DefinitionsOrganic SalesOrganic Sales is defined as net sales excluding the impacts of currency and portfolio.Adjusted EarningsAdjusted Earnings is defined as income from continuing operations excluding the after-tax impact of significant items, after-tax impact of amortization expense of intangibles, the after-tax impact of non-operating pension / other post employment benefits ("OPEB") credits / costs, Future Reimbursable Indirect Costs and Corporate DDOB Remediation Costs.Adjusted Earnings is the numerator used in the calculation of Adjusted EPS, as well as the denominator in Adjusted Free Cash Flow Conversion.Adjusted EPSAdjusted EPS is defined as Adjusted Earnings per common share - diluted. Management estimates amortization expense in 2026 associated with intangibles to be about $270 million on a pre-tax basis, or approximately $0.50 per share.Operating EBITDA, EBITDA Margin & Incremental MarginThe Company's measure of profit/loss for segment reporting purposes is Operating EBITDA as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines Operating EBITDA as earnings (i.e., "Income from continuing operations before income taxes") before interest, depreciation, amortization, non-operating pension / OPEB benefits / charges, and foreign exchange gains / losses, excluding Future Reimbursable Indirect Costs, Corporate DDOB Remediation Costs, and adjusted for significant items. Reconciliations of these measures are provided on the following pages.Operating EBITDA Margin is defined as Operating EBITDA divided by Net Sales.Incremental Margin is the change in Operating EBITDA divided by the change in Net Sales for the applicable period.Adjusted Free Cash Flow & Adjusted Free Cash Flow Conversion Adjusted Free Cash Flow is defined as cash provided by/used for operating activities from continuing operations less capital expenditures and excluding the impact of cash inflows/outflows that are unusual in nature and/or infrequent in occurrence that neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business liquidity. As a result, Adjusted Free Cash Flow represents cash that is available to the Company, after investing in its asset base, to fund obligations using the Company's primary source of liquidity, cash provided by operating activities from continuing operations. Management believes Adjusted Free Cash Flow, even though it may be defined differently from other companies, is useful to investors, analysts and others to evaluate the Company's cash flow and financial performance, and it is an integral measure used in the Company's financial planning process. Management notes that there were no exclusions for items that are unusual in nature and/or infrequent in occurrence for the three and twelve-month periods ended December 31, 2025 and December 31, 2024.Adjusted Free Cash Flow Conversion is defined as Adjusted Free Cash Flow divided by Adjusted Earnings. Management uses Adjusted Free Cash Flow Conversion as an indicator of our ability to convert earnings to cash.Transaction Adjusted Free Cash Flow & Transaction Adjusted Free Cash Flow Conversion Management believes supplemental non-GAAP financial measures including Transaction-Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow Conversion (each defined below) provide an integral view of information on the Company's underlying business performance during this period of transformational change. Management believes the Electronics Separation and Aramids Divestiture collectively represent a significant transformational change for the Company and separation-related transaction cost payments impact comparability to the Company's continuing operations. Management believes Transaction-Adjusted Free Cash Flow, which may be defined differently from other companies, is useful to investors, analysts and others to evaluate the Company's cash flow and financial performance, and it is an integral measure used in the Company's financial planning process. These non-GAAP financial measures are not intended to represent residual cash flow for discretionary expenditures since other non-discretionary expenditures, such as mandatory debt service requirements, are not deducted from the measure.Transaction-Adjusted Free Cash Flow is defined as cash provided by/used for operating activities from continuing operations less capital expenditures and removing the impact of separation-related transaction costs and other payment and cash inflows/outflows that are unusual in nature and/or infrequent in occurrence that neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business liquidity.Transaction-Adjusted Free Cash Flow Conversion is defined as Transaction-Adjusted Free Cash Flow excluding separation-related transaction costs, divided by Adjusted Earnings.Separation-related transaction costs and other payments include cash outflows directly associated with the Electronics Separation and the Aramids Divestiture. These costs include advisor and banking fees, payments related to establishing a new capital structure (including fees associated with interest rate swaps), capital expenditures required to facilitate physical asset separation, restructuring payments associated with senior leadership, and Future Reimbursable Indirect Costs, among other expenditures.Future Reimbursable Indirect Costs are excluded from Adjusted Earnings and Operating EBITDA. To provide comparable data analysis, the Company has also adjusted payments associated with Future Reimbursable Indirect Costs within Separation-related transaction costs and other payments. This adjustment is intended to provide insight into the Company's underlying business performance. For the three and twelve months ended December 31, 2025, the Company adjusted $11 million and $70 million, respectively associated with Future Reimbursable Indirect Costs within Separation-related transaction costs and other payments.For the twelve months ended December 31, 2025, the Company paid $123 million in fees associated with the settlement of interest rate swaps related to the 2048 notes, representing the allocated of the fair value of the swaps at the time of settlement, and $21 million in fees associated with the debt exchange. A total of $124 million and $144 million were reflected in Separation-related transaction costs and other payments for the three and twelve month periods ended December 31, 2025, respectively, these amounts related to achieving the post Electronics Separation capital structure.Additionally, $4 million and $16 million were reflected in Separation-related transaction costs and other payments for the three and twelve month periods ended December 31, 2025, respectively, for expenditures incurred to complete the physical separation of shared locations.Finally, $9 million of restructuring and other separation payments to senior leadership were reflected in Separation-related transaction costs and other payments for the three and twelve month periods ended December 31, 2025. These payments were reflected in other cash payments as they related to the establishment of the post-spin leadership structure. DuPont de Nemours, Inc.Consolidated Statements of Operations 

Three Months Ended December 31,Twelve Months Ended December 31,In millions, except per share amounts (Unaudited)2025202420252024Net sales$       1,693$       1,689$       6,849$       6,719Cost of sales1,0951,1364,4864,499Research and development expenses3851193203Selling, general and administrative expenses2622271,019976Amortization of intangibles7176291294Restructuring and asset related charges - net94915157Acquisition, integration and separation costs365920390Equity in (loss) earnings of nonconsolidated affiliates(1)—(7)(6)Sundry income (expense) - net(101)(246)14(111)Interest expense6184313366(Loss) income from continuing operations before income taxes$           (66)$        (199)$          200$          117Provision for income taxes on continuing operations4292102213(Loss) income from continuing operations, net of tax$        (108)$        (291)$             98$           (96)(Loss) income from discontinued operations, net of tax(12)185(836)834Net (loss) income $        (120)$        (106)$        (738)$          738Net income attributable to noncontrolling interests6114135Net (loss) income available for DuPont common stockholders$        (126)$        (117)$        (779)$          703









Per common share data:



(Loss) earnings per common share from continuing operations - basic$       (0.27)$       (0.70)$         0.21$       (0.23)(Loss) earnings per common share from discontinued operations - basic(0.03)0.42(2.08)1.91(Loss) earnings per common share - basic$       (0.30)$       (0.28)$       (1.87)$         1.68(Loss) earnings per common share from continuing operations - diluted$       (0.27)$       (0.70)$         0.21$       (0.23)(Loss) earnings per common share from discontinued operations - diluted(0.03)0.42(2.07)1.91(Loss) earnings per common share - diluted$       (0.30)$       (0.28)$       (1.86)$         1.68




Weighted-average common shares outstanding - basic413.7418.3417.5419.2Weighted-average common shares outstanding - diluted413.7418.3419.2419.2 DuPont de Nemours, Inc.Consolidated Balance Sheets 
In millions, except share amounts (Unaudited)December 31, 2025December 31, 2024Assets

Current Assets

Cash and cash equivalents$                                 715$                             1,792Restricted cash and cash equivalents426Accounts and notes receivable - net1,6691,342Inventories1,1721,130Prepaid and other current assets121125Assets of discontinued operations1,85616,380Total current assets$                             5,575$                           20,775Property, plant and equipment - net of accumulated depreciation (December 31, 2025 -
$3,565; December 31, 2024 - $3,477)3,4643,454Other Assets

Goodwill7,9157,561Other intangible assets2,9363,178Restricted cash and cash equivalents - noncurrent—36Investments and noncurrent receivables432418Deferred income tax assets282237Deferred charges and other assets971977Total other assets$                           12,536$                           12,407Total Assets$                           21,575$                           36,636Liabilities and Equity

Current Liabilities

Short-term borrowings$                                  60$                             1,848Accounts payable9951,054Income taxes payable5479Accrued and other current liabilities882784Liabilities of discontinued operations3141,731Total current liabilities$                             2,305$                             5,496Long-Term Debt3,1345,323Other Noncurrent Liabilities

Deferred income tax liabilities405524Pension and other post-employment benefits - noncurrent432432Other noncurrent obligations1,1961,068Total other noncurrent liabilities$                             2,033$                             2,024Total Liabilities$                             7,472$                           12,843Commitments and contingent liabilities

Stockholders' Equity

Common stock (authorized 1,666,666,667 shares of $0.01 par value each; issued 2025:
409,195,445 shares; 2024: 417,994,343 shares)44Additional paid-in capital38,71847,922Accumulated deficit(24,278)(23,076)Accumulated other comprehensive loss(525)(1,500)Total DuPont stockholders' equity$                           13,919$                           23,350Noncontrolling interests184443Total equity$                           14,103$                           23,793Total Liabilities and Equity$                           21,575$                           36,636 DuPont de Nemours, Inc.Consolidated Statement of Cash Flows 

Year Ended December 31,In millions (Unaudited)20252024Operating Activities

Net (loss) income$                       (738)$                         738(Loss) income from discontinued operations(836)834Net income (loss) from continuing operations$                           98$                         (96)Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization647635Provision (credit) for deferred income tax and other tax related items13(92)Earnings of nonconsolidated affiliates in excess of dividends received85Net periodic pension benefit cost (credit) 3(1)Periodic benefit plan contributions(44)(43)Net gain on sales, businesses and investments(3)(4)Restructuring and asset related charges - net15157Stock based compensation3856Loss on debt extinguishment9974Interest rate swap (gain) loss(31)138Interest rate swap termination(123)—Donatelle contingent earn-out true-up(19)—Other net loss (income)36(23)Changes in assets and liabilities, net of effects of acquired and divested companies:

Accounts and notes receivable(201)(83)Inventories(10)61Accounts payable61(36)Other assets and liabilities, net(163)117Cash provided by operating activities - continuing operations$                         560$                         765Investing Activities

Capital expenditures(333)(285)Proceeds and adjustments to proceeds from sales of property and businesses, net of cash divested—(7)Acquisitions of property and businesses, net of cash acquired(55)(313)Other investing activities, net1443Cash used for investing activities - continuing operations$                       (374)$                       (562)Financing Activities

Changes in short-term borrowings60—Distribution from Electronics at spin-off4,100—Payments on long-term debt and fees(4,134)(687)Purchases of common stock and forward contracts(500)(500)Proceeds from issuance of Company stock3250Employee taxes paid for share-based payment arrangements(26)(27)Distributions to noncontrolling interests(9)(5)Dividends paid to stockholders(597)(635)Cash transferred to Electronics at spin-off(664)—Payment of excise tax on purchase of treasury stock(8)(21)Other financing activities, net(4)(1)Cash used for financing activities - continuing operations$                    (1,750)$                    (1,826)Cash Flows from Discontinued Operations

Cash provided by operations - discontinued operations8521,082Cash used for investing activities - discontinued operations(313)(287)Cash used for financing activities - discontinued operations(118)(21)Cash provided by discontinued operations$                         421$                         774Effect of exchange rate changes on cash, cash equivalents and restricted cash11(62)Decrease in cash, cash equivalents and restricted cash$                    (1,132)$                       (911)Cash, cash equivalents and restricted cash from continuing operations, beginning of period1,8342,755Cash, cash equivalents and restricted cash from discontinued operations, beginning of period5848Cash, cash equivalents and restricted cash at beginning of period$                      1,892$                      2,803Cash, cash equivalents and restricted cash from continuing operations, end of period7571,834Cash, cash equivalents and restricted cash from discontinued operations, end of period358Cash, cash equivalents and restricted cash at end of period$                         760$                      1,892 DuPont de Nemours, Inc.Net Sales by Segment and Geographic Region
Net Sales by Segment and Geographic RegionThree Months EndedTwelve Months EndedIn millions (Unaudited)Dec 31, 2025Dec 31, 2024Dec 31, 2025Dec 31, 2024Healthcare & Water Technologies$                 821$                 790$             3,233$             2,976Diversified Industrials8728993,6163,743Total$             1,693$             1,689$             6,849$             6,719U.S. & Canada$                 839$                 845$             3,415$             3,371EMEA 13573331,4681,379Asia Pacific 24194311,6401,647Latin America7880326322Total$             1,693$             1,689$             6,849$             6,719 Net Sales Variance by Segment and
Geographic RegionThree Months Ended December 31, 2025
Local Price &
Product MixVolumeTotalOrganicCurrencyPortfolio / OtherTotal
Percent change from prior year (Unaudited)
Healthcare & Water Technologies— %3 %3 %1 %— %4 %
Diversified Industrials—(4)(4)1—(3)
Total— %(1) %(1) %1 %— %— %
U.S. & Canada2 %(2) %— %(1) %— %(1) %
EMEA 1(1)325—7
Asia Pacific 2(2)—(2)(1)—(3)
Latin America(2)(1)(3)——(3)
Total— %(1) %(1) %1 %— %— %
 Net Sales Variance by Segment and
Geographic RegionTwelve Months Ended December 31, 2025
Local Price &
Product MixVolumeTotalOrganicCurrencyPortfolio /
OtherTotal
Percent change from prior year (Unaudited)
Healthcare & Water Technologies— %7 %7 %1 %1 %9 %
Diversified Industrials(1)(1)(2)—(1)(3)
Total(1) %3 %2 %— %— %2 %
U.S. & Canada— %1 %1 %(1) %1 %1 %
EMEA 1(1)43216
Asia Pacific 2(1)54—(4)—
Latin America(2)31——1
Total(1) %3 %2 %— %— %2 %
1.Europe, Middle East and Africa.2.Net sales attributed to China/Hong Kong, for the three months ended December 31, 2025 and 2024 were $184 million and $188 million, respectively, while for the twelve months ended December 31, 2025 and 2024 net sales attributed to China/Hong Kong were $708 million and $763 million, respectively. DuPont de Nemours, Inc.Selected Financial Information and Non-GAAP Measures 


Operating EBITDA by Segment Three Months EndedTwelve Months Ended
In millions (Unaudited)Dec 31, 2025Dec 31, 2024Dec 31, 2025Dec 31, 2024
Healthcare & Water Technologies$               255$               246$               972$               844
Diversified Industrials197193800839
Corporate 1(43)(44)(144)(152)
Total$               409$               395$            1,628$            1,531
1. Corporate includes expenses of the Corporate function not allocated to specific business in the Company.








Equity in Earnings of Nonconsolidated Affiliates by SegmentThree Months EndedTwelve Months Ended
In millions (Unaudited)Dec 31, 2025Dec 31, 2024Dec 31, 2025Dec 31, 2024
Healthcare & Water Technologies$                   1$                   1$                   2$                   1
Diversified Industrials——(1)—
Corporate 1(2)(1)(8)(7)
Total equity earnings included in operating EBITDA (GAAP)$                 (1)$                 —$                 (7)$                 (6)
1. Corporate includes the equity interest acquired in the Delrin® Divestiture transaction.








Reconciliation of "Income from continuing operations, net of tax" to "Operating EBITDA" Three Months EndedTwelve Months Ended

In millions (Unaudited)Dec 31, 2025Dec 31, 2024Dec 31, 2025Dec 31, 2024
Income from continuing operations, net of tax (GAAP)$             (108)$             (291)$                 98$               (96)
+ Provision for income taxes on continuing operations4292102213
Income from continuing operations before income taxes $               (66)$             (199)$               200$               117
+ Depreciation and amortization159163647635
- Interest income 1, 220197274
+ Interest expense 36184311365
- Non-operating pension/OPEB benefit (costs) credits 13259
- Foreign exchange losses, net 1(5)16(34)(3)
+ Future reimbursable indirect costs142589100
+ Remediation costs associated with divested businesses431214
+ Significant items (charge) benefit (255)(356)(412)(380)
Operating EBITDA (non-GAAP)$               409$               395$            1,628$            1,531
1.Included in "Sundry income (expense) - net".2.The three and twelve months ended December 31, 2025 excludes accrued interest income earned on employee retention credits and interest income earned on cash held in escrow associated with the Qnity financing. Refer to details of significant items on pages 16-17.3.The three and twelve months ended December 31, 2025 excludes interest rate swap basis amortization. Refer to details of significant items on pages 16-17. Reconciliation of "Cash provided by operating activities - continuing
operations" to Adjusted Free Cash Flow 1 , Transaction-Adjusted Free
Cash Flow1 and calculation of "Adjusted Free Cash Flow Conversion"
and "Transaction-Adjusted Free Cash Flow Conversion"Three Months EndedTwelve Months EndedIn millions (Unaudited)Dec 31, 2025Dec 31, 2024Dec 31, 2025Dec 31, 2024Cash provided by operating activities (GAAP) 2 - continuing operations$              87$            161$            560$            765Capital expenditures(87)(71)(333)(285)Adjusted free cash flow (non-GAAP)$              —$              90$            227$            480Separation-related transaction cost and other payments322829462107Transaction-adjusted free cash flow (non-GAAP)$            228$            119$            689$            587




Adjusted earnings (non-GAAP) 4$            193$            165$            704$            613Adjusted free cash flow conversion (non-GAAP)— %55 %32 %78 %Transaction-adjusted free cash flow conversion (non-GAAP)118 %72 %98 %96 %1.Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow are calculated on a continuing operations basis for all periods presented. Refer to the definitions of Non-GAAP metrics on pages 9-10 for additional information.2.Refer to the Consolidated Statement of Cash Flows included in the schedules above for major GAAP cash flow categories as well as further detail relating to the changes in "Cash provided by operating activities - continuing operations" for the twelve month periods noted.3.Other payments for the year ended December 31, 2025 includes $144 million for interest rate swap settlements and debt exchange fees that were related to achieving the post-spin capital structure for new DuPont, $9 million related to restructuring related compensation cash payments for certain executive officers, $16 million of separation-related capital expenditures and $70 million for Future Reimbursable Indirect Costs (as defined in our Non-GAAP definitions).4.Refer to pages 16-17 for the Non-GAAP reconciliations of Net income from continuing operations available for DuPont common stockholders to Adjusted Earnings (Non-GAAP). DuPont de Nemours, Inc.Selected Financial Information and Non-GAAP Measures 
Significant Items Impacting Results for the Three Months Ended December 31, 2025In millions, except per share amounts (Unaudited)Pretax 1Net Income 2EPS 3Income Statement ClassificationReported earnings (GAAP)$        (66)$      (111)$     (0.27)
Less: Significant items



Acquisition, integration & separation costs(36)(31)(0.08)Acquisition, integration and separation costsRestructuring and asset related charges - net(94)(72)(0.17)Restructuring and asset related charges - netLoss on debt extinguishment 4(114)(88)(0.21)Sundry income (expense) - netInterest rate swap mark-to-market loss 5(17)(13)(0.03)Sundry income (expense) - netQnity financing 6650.01Sundry income (expense) - netOther benefits (credits), net 7———Sundry income (expense) - net; Selling, general and
administrative expensesIncome tax items 8—(39)(0.09)Provision for income taxes on continuing operationsTotal significant items$      (255)$      (238)$     (0.57)
Less: Amortization of intangibles(71)(55)(0.13)Amortization of intangiblesLess: Non-op pension / OPEB benefit costs330.01Sundry income (expense) - netLess: Future reimbursable indirect costs(14)(11)(0.03)Selling, general and administrative expensesLess: Corporate DDOB remediation costs(4)(3)(0.01)Selling, general and administrative expensesAdjusted earnings (non-GAAP)$        275$        193$       0.46
 Significant Items Impacting Results for the Three Months Ended December 31, 2024In millions, except per share amounts (Unaudited)Pretax 1Net Income 2EPS 3Income Statement ClassificationReported earnings (GAAP)$      (199)$      (294)$     (0.70)
Less: Significant items



Acquisition, integration and separation costs(59)(46)(0.11)Acquisition, integration and separation costsRestructuring and asset related charges - net(9)(7)(0.02)Restructuring and asset related charges - netInventory write-offs 921—Cost of salesInterest rate swap mark-to-market loss 10(290)(222)(0.53)Sundry income (expense) - netIncome tax items 11—(106)(0.24)Provision for income taxes on continuing operationsTotal significant items$      (356)$      (380)$     (0.90)
Less: Amortization of intangibles(76)(60)(0.14)Amortization of intangiblesLess: Non-op pension / OPEB benefit credits22—Sundry income (expense) - netLess: Future reimbursable indirect costs(25)(19)(0.04)Selling, general and administrative expensesLess: Corporate DDOB remediation costs(3)(2)(0.01)Selling, general and administrative expensesAdjusted earnings (non-GAAP)$        259$        165$       0.39
1.Income (loss) from continuing operations before income taxes.2.Net income (loss) from continuing operations available for DuPont common stockholders. The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.3.Earnings (loss) per common share from continuing operations - diluted.4.Includes $15 million of treasury transaction-related fees in addition to $99 million loss on debt extinguishment related to the Debt Exchange, Special Mandatory Redemption, Consent Solicitation and Tender Offer.5.The three months ended December 31, 2025 includes the non-cash mark-to-market net loss related to the 2022 Swaps and 2024 Swaps and the interest settlement loss on the 2022 Swaps.6.Includes interest income earned on cash held in escrow associated with the Qnity notes.7.Reflects the accrued interest earned on employee retention credits ($5 million pre-tax), and a benefit related to an indemnification receivable for a tax matter ($3 million pre-tax) offset by legal costs within the Healthcare & Water segment associated with a pending intellectual property matter ($8 million pre-tax).8.Reflects the income tax impact of certain internal restructurings related to the Electronics Separation.9.Reflects an adjustment to raw material inventory write-offs recorded in "Cost of Sales" in connection with restructuring actions related to plant line closures within the Healthcare & Water segment.10.The three months ended December 31, 2024 includes non-cash mark-to-market loss related to the 2022 Swaps and 2024 Swaps and the interest settlement loss on the 2022 Swaps.11.Reflects the impact of an international tax audit. DuPont de Nemours, Inc.Selected Financial Information and Non-GAAP Measures 
Significant Items Impacting Results for the Twelve Months Ended December 31, 2025In millions, except per share amounts (Unaudited)Pretax 1Net Income 2EPS 3Income Statement ClassificationReported losses (GAAP)$        200$          88$       0.21
Less: Significant items



Acquisition, integration & separation costs(203)(162)(0.39)Acquisition, integration and separation costsRestructuring and asset related charges - net(151)(118)(0.28)Restructuring and asset related charges - netLoss on debt extinguishment 4(114)(88)(0.21)Sundry income (expense) - netInterest rate swap mark-to-market gain 529240.06Sundry income (expense) - net; interest expenseQnity financing 615120.03Sundry income (expense) - netOther benefits (credits), net 71290.01Sundry income (expense) - net; Selling, general and
administrative expensesIncome tax items 8—70.02Provision for income taxes on continuing operationsTotal significant items$      (412)$      (316)$     (0.76)
Less: Amortization of intangibles(291)(227)(0.54)Amortization of intangiblesLess: Non-op pension / OPEB benefit credits550.01Sundry income (expense) - netLess: Future reimbursable indirect costs(89)(69)(0.16)Selling, general and administrative expensesLess: Corporate DDOB remediation costs(12)(9)(0.02)Selling, general and administrative expensesAdjusted earnings (non-GAAP)$        999$        704$       1.68
 Significant Items Impacting Results for the Twelve Months Ended December 31, 2024In millions, except per share amounts (Unaudited)Pretax 1Net Income 2EPS 3Income Statement ClassificationReported earnings (GAAP)$        117$        (98)$     (0.23)
Less: Significant items



Acquisition, integration and separation costs (90)(75)(0.18)Acquisition, integration and separation costsRestructuring and asset related charges - net (57)(44)(0.10)Restructuring and asset related charges - netInventory write-offs 9(25)(20)(0.05)Cost of salesLoss on debt extinguishment 10(74)(57)(0.14)Sundry income (expense) - netInterest rate swap mark-to-market loss 11(139)(104)(0.25)Sundry income (expense) - net; interest expenseOther benefits (credits), net 12(2)(1)—Costs of salesIncome tax items 137(99)(0.23)Sundry income (expense) - net; Provision for
income taxes on continuing operationsTotal significant items$      (380)$      (400)$     (0.95)
Less: Amortization of intangibles(294)(231)(0.55)Amortization of intangiblesLess: Non-op pension / OPEB benefit credits970.02Sundry income (expense) - netLess: Future reimbursable indirect costs(100)(77)(0.18)Selling, general and administrative expensesLess: Corporate DDOB remediation costs(14)(10)(0.02)Selling, general and administrative expensesAdjusted earnings (non-GAAP)$        896$        613$       1.45
1.Income (loss) from continuing operations before income taxes.2.Net income (loss) from continuing operations available for DuPont common stockholders. The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.3.Earnings (loss) per common share from continuing operations - diluted.4.Includes $15 million of treasury transaction-related fees in addition to $99 million loss on debt extinguishment related to the Debt Exchange, Special Mandatory Redemption, Consent Solicitation and Tender Offer.5.The twelve months ended December 31, 2025 includes the non-cash mark-to-market net gain related to the 2022 Swaps and 2024 Swaps offset by the interest settlement loss on the 2022 Swaps. The year ended December 31, 2025 also includes basis amortization on the 2022 Swaps ($2 million pre-tax, reflected in "Interest expense" within the Consolidated Statements of Operations).6.Includes interest income earned on cash held in escrow associated with the Qnity notes.7.Reflects benefits related to an adjustment of the Donatelle contingent earn-out liability ($19 million pre-tax), accrued interest earned on employee retention credits ($11 million pre-tax), a benefit related to an indemnification receivable for a tax matter ($3 million pre-tax) offset by legal costs within the Healthcare & Water segment associated with a pending intellectual property matter ($22 million pre-tax).8.Reflects the income tax impact of certain internal restructurings related to the Electronics Separation.9.Reflects net raw material inventory write-offs recorded in "Cost of Sales" in connection with restructuring actions related to plant line closures within the Healthcare & Water segment.10.Reflects the loss on extinguishment of debt related to the partial redemption of the 2038 notes.11.The year ended December 31, 2024 includes non-cash mark-to-market loss related to the 2022 Swaps and 2024 Swaps and the interest settlement loss on the 2022 Swaps. The year ended December 31, 2024 also includes basis amortization on the 2022 Swaps ($1 million pre-tax, reflected in "Interest expense" within the Consolidated Statements of Operations).12.Reflects credit for the amortization of an inventory step-up adjustment related to the Donatelle Plastics acquisition ($2 million pre-tax).13.Reflects the impact of an international tax audit. 



View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-reports-fourth-quarter-and-full-year-2025-results-302683207.htmlSOURCE DuPont

Original: DuPont Reports Fourth Quarter and Full Year 2025 Results

Qnity's share of capitalization was near 30% of DuPont, and the immediate drop after the spin-off exceeded 58%. This is a clear sign of undervaluation - DuPont is a chemical giant with a two-century history, stable and predictable, not something incomprehensible like Beyond Meat for example... And the very important thing - DuPont had plans to buy back 3 billion of its own shares... which didn't change after the spin-off. Naturally, they will definitely buy back the shares after they fell so much. Steady growth without sharp jumps over the past couple of days indicates a smart buyback. I'm not a pro trader, but in my opinion, this is the most interesting position now. Normalization may occur raise up to near 50 in several days.

Should go up November 1

DD 10Q due 5/2

DD, new 52 week low

DuPont Reports Fourth Quarter and Full Year 2024 Results; Initiates 2025 Financial Guidance
https://ih.advfn.com/stock-market/NYSE/dupont-de-nemours-DD/stock-news/95408629/dupont-reports-fourth-quarter-and-full-year-2024-results-initiates-2025-financi

https://ih.advfn.com/stock-market/NYSE/dupont-de-nemours-DD/stock-news/94842615/dupont-reports-third-quarter-2024-results

DD 10Q 11/5

DD new 52 week high

DD new 52 week high

DuPont Reports Second Quarter 2024 Results

Source: PR Newswire (US)
Net Sales of $3.2 billion increased 2%; organic sales flat versus year-ago period
GAAP Income from continuing operations of $176 million; operating EBITDA of $798 million
GAAP EPS from continuing operations of $0.40; adjusted EPS of $0.97
Cash provided by operating activities from continuing operations of $527 million; adjusted free cash flow of $425 million
Raises full year 2024 guidance for net sales, operating EBITDA and adjusted EPS

DuPont Completes Acquisition of Donatelle Plastics Incorporated

Source: PR Newswire (US)
WILMINGTON, Del., July 29, 2024 /PRNewswire/ -- DuPont (NYSE: DD) today announced that it has completed the previously announced acquisition of Donatelle Plastics ("Donatelle"), a leading medical device company specializing in medical components and devices.

DuPont Logo (PRNewsfoto/DuPont)

"I'm pleased to welcome the talented Donatelle colleagues to DuPont," said Jon Kemp, President, DuPont Electronics & Industrial (E&I). "We're excited to add Donatelle's best-in-class advanced injection molding manufacturing capabilities, and decades-long customer relationships with large medical device equipment manufacturers to E&I's healthcare offerings."

With a workforce of more than 400 employees, Donatelle becomes part of the Industrial Solutions line of business within the Electronics & Industrial segment. The acquisition of Donatelle brings complementary advanced technologies and capabilities including medical device injection molding, liquid silicone rubber processing, precision machining, device assembly, and tool building. Donatelle has a strong growth profile with offerings aligned to attractive therapeutic areas including electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neurostimulation, and orthopedic extremities.

About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-completes-acquisition-of-donatelle-plastics-incorporated-302208211.html

SOURCE DuPont


Copyright 2024 PR Newswire

DuPont Reports First Quarter 2024 Results

Source: PR Newswire (US)
Net Sales of $2.9 billion decreased 3%; organic sales decreased 6% versus year-ago period
GAAP Income from continuing operations of $183 million; operating EBITDA of $682 million
GAAP EPS from continuing operations of $0.41; adjusted EPS of $0.79
Cash provided by operating activities from continuing operations of $493 million; adjusted free cash flow of $286 million
$500 million accelerated share repurchase (ASR) transaction launched in February was completed in April
Raises full year 2024 guidance for net sales, operating EBITDA and adjusted EPS
WILMINGTON, Del., May 1, 2024 /PRNewswire/ -- DuPont (NYSE: DD) announced its financial results(1) for the first quarter ended March 31, 2024.

DuPont Logo (PRNewsfoto/DuPont)

"First quarter 2024 financial results exceeded our expectations driven by better-than-expected volumes along with a continued focus by our teams on operational execution and cost discipline," said Ed Breen, DuPont Executive Chairman and Chief Executive Officer. "The first quarter was encouraging as the electronics market saw continued recovery, demonstrated by 11 percent year-over-year volume growth in Semiconductor Technologies and another quarter of volume growth in Interconnect Solutions. Channel inventory destocking within our industrial-based businesses has bottomed and assumed recovery timing is on track with our previous expectations. In addition, we delivered significant year-over-year cash flow improvement during the first quarter driven by our continued focus on working capital improvement," Breen concluded.

First Quarter 2024 Results(1)




Dollars in millions, unless noted



1Q'24



1Q'23

Change

vs. 1Q'23

Organic Sales (2)

vs. 1Q'23

Net sales

$2,931

$3,018

(3) %

(6) %

GAAP Income from continuing operations

$183

$273

(33) %


Operating EBITDA(2)

$682

$714

(4) %


Operating EBITDA(2) margin %

23.3 %

23.7 %

(40) bps


GAAP EPS from continuing operations

$0.41

$0.58

(29) %


Adjusted EPS(2)

$0.79

$0.84

(6) %


Cash provided by operating activities – cont. ops.

$493

$405

22 %


Adjusted free cash flow(2)

$286

$173

65 %


Net sales

Net sales decreased 3% as organic sales(2) decline of 6% and currency headwind of 1% was partially offset by a favorable portfolio impact of 4%, primarily reflecting the August 2023 Spectrum acquisition.
Organic sales(2) decline of 6% consisted of a 5% decrease in volume and a 1% decrease in price.
Lower volume was driven by the impact of continued channel inventory destocking in industrial-based businesses, including for water technologies mainly in China and medical packaging within Safety Solutions, partially offset by strong growth within electronics markets.
10% organic sales(2) decline in Water & Protection; 2% organic sales(2) decline in Electronics & Industrial; 1% organic sales(2) growth in the retained businesses reported in Corporate.
8% organic sales(2) decline in EMEA; 7% organic sales(2) decline in U.S. & Canada; 4% organic sales(2) decline in Asia Pacific.
GAAP Loss from continuing operations

GAAP income/GAAP EPS from continuing operations decreased due primarily to higher charges related to restructuring activities, lower segment earnings and higher net interest expense partially offset by the benefit of a lower share count.
Operating EBITDA(2)

Operating EBITDA(2) decreased as volume declines were partially offset by the impact of lower product costs and the earnings contribution from the Spectrum acquisition.
Adjusted EPS(2)

Adjusted EPS(2) decreased as lower segment earnings and higher net interest expense more than offset the benefit of a lower share count.
Cash provided by operating activities from continuing operations

Cash provided by operating activities from continuing operations in the quarter of $493 million and capital expenditures of $207 million resulted in adjusted free cash flow(2) of $286 million. Adjusted free cash flow conversion(2) during the quarter was 86%.


(1)

Results and cash flows are presented on a continuing operations basis. See page 5 for further information, including the basis of presentation included in this release.

(2)

Organic sales, operating EBITDA, operating EBITDA margin, adjusted EPS, adjusted free cash flow and adjusted free cash flow conversion are non-GAAP measures and only reflect continuing operations. See page 6 for further discussion, including a definition of significant items. Reconciliation to the most directly comparable GAAP measure, including details of significant items begins on page 11 of this communication. Adjusted EPS outlook on page 3 assumes the $1B share repurchase program is substantially complete by year-end 2024.

(3)

During first quarter 2024, the Company realigned the management and reporting structure of certain product lines within the three E&I lines of business. E&I line of business revenue amounts for historical periods have been recast to conform to the new structure.

First Quarter 2024 Segment Highlights

Electronics & Industrial



Dollars in millions, unless noted



1Q'24



1Q'23

Change

vs. 1Q'23

Organic Sales(2)

vs. 1Q'23

Net sales

$1,365

$1,296

5 %

(2) %

Operating EBITDA

$374

$362

3 %


Operating EBITDA margin %

27.4 %

27.9 %

(50) bps


Net sales

Net sales increased 5% as favorable portfolio impact of 8% primarily reflecting the Spectrum acquisition was partially offset by organic sales(2) decline of 2% and a currency headwind of 1%.
Organic sales(2) decline of 2% reflects a 1% decline in price and a 1% decline in volume.
Semiconductor Technologies(3) sales up 10% on an organic basis driven by the start of semiconductor demand recovery and normalization of customer inventory levels, along with increased demand for OLED materials.
Interconnect Solutions(3) sales up slightly on an organic basis as mid-single digit volume gains were mostly offset by the impact of lower pass-through metals prices.
Industrial Solutions(3) sales down about 20% on an organic basis due primarily to ongoing channel inventory destocking for Kalrez® parts and within biopharma markets.
Operating EBITDA

Operating EBITDA increased as strength in Semiconductor Technologies and Interconnect Solutions and the earnings contribution from the Spectrum acquisition was partially offset by the impact of lower volumes in Industrial Solutions.


Water & Protection



Dollars in millions, unless noted



1Q'24



1Q'23

Change

vs. 1Q'23

Organic Sales(2)

vs. 1Q'23

Net sales

$1,291

$1,449

(11) %

(10) %

Operating EBITDA

$295

$344

(14) %


Operating EBITDA margin %

22.9 %

23.7 %

(80) bps


Net sales

Net sales decreased 11% due to a 10% decrease in volume and a currency headwind of 1%.
Safety Solutions sales down low-teens on an organic(2) basis on volume declines driven mainly by channel inventory destocking, most notably for medical packaging products within healthcare markets.
Water Solutions sales down mid-teens on an organic(2) basis driven by lower volumes resulting from distributor inventory destocking and weaker industrial demand in China.
Shelter Solutions sales flat on an organic(2) basis.
Operating EBITDA

Operating EBITDA decreased due to lower volumes partially offset by the impact of lower product costs.
Financial Outlook

Dollars in millions, unless noted

2Q'24E

Full Year 2024E

Net sales

~$3,025

$12,100 - $12,400

Operating EBITDA(2)

~$710

$2,900 - $3,050

Adjusted EPS(2)

~$0.84

$3.45 - $3.75

"We are raising our financial guidance for the year for net sales, operating EBITDA and adjusted EPS," said Lori Koch, Chief Financial Officer of DuPont. "At the mid-point of our updated guidance ranges for full year 2024, we now estimate net sales of about $12.25 billion, operating EBITDA of about $2.975 billion and adjusted EPS of $3.60 per share."

"For the second quarter of 2024, we expect sequential sales and earnings improvement driven by favorable seasonality, continued electronics recovery, and reduced channel inventory destocking in industrial-based end-markets including water and medical packaging" Koch continued. "Year-over-year sales and earnings growth assumed in the second half of 2024 is expected to be driven by further electronics market recovery and a return to volume growth in W&P."

Conference Call
The Company will host a live webcast of its quarterly earnings conference call with investors to discuss its results and business outlook beginning today at 8:00 a.m. ET. The slide presentation that accompanies the conference call will be posted on the DuPont's Investor Relations Events and Presentations page. A replay of the webcast also will be available on the DuPont's Investor Relations Events and Presentations page following the live event.

About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPontTM and all products, unless otherwise noted, denoted with TM, SM or ® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc.

Overview
On November 1, 2023, DuPont completed the divestiture of the Delrin® acetal homopolymer (H-POM) business to TJC LP, (the "Delrin® Divestiture"). The results of operations for the three months ended March 31, 2023 present the financial results of the Delrin® Divestiture as discontinued operations. Unless otherwise indicated, the discussion of results, including the financial measures further discussed below, refers only to DuPont's Continuing Operations and does not include discussion of balances or activity of the Delrin® Divestiture.

Effective as of January 1, 2024, Electronics & Industrial realigned certain product lines that comprise its business units (Industrial Solutions, Interconnect Solutions and Semiconductor Technologies) that are intended to optimize business operations across the segment leading to enhanced value for our customers and cost savings. The realignment did not result in changes to total Electronics and Industrial segment net sales.

Cautionary Statement about Forward-looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," "stabilization," "confident," "preliminary," "initial," and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements, including statements regarding outlook, expectations and guidance.

Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: i) the possibility that the Company may fail to realize the anticipated benefits of the $1 billion share repurchase program announced on February 6, 2024 and that the program may be suspended, discontinued or not completed prior to its termination on June 30, 2025; (ii) risks and uncertainties related to the settlement agreement concerning PFAS liabilities reached June 2023 with plaintiff water utilities by Chemours, Corteva, EIDP and DuPont; (iii) risks and costs related to each of the parties respective performance under and the impact of the arrangement to share future eligible PFAS costs by and between DuPont, Corteva and Chemours, including the outcome of any pending or future litigation related to PFAS or PFOA, including personal injury claims and natural resource damages claims; the extent and cost of ongoing remediation obligations and potential future remediation obligations; changes in laws and regulations applicable to PFAS chemicals; (iv) ability to achieve anticipated tax treatments in connection with completed and future, if any, divestitures, mergers, acquisitions and other portfolio changes actions and impact of changes in relevant tax and other laws; (v) indemnification of certain legacy liabilities; (vi) failure to realize expected benefits and effectively manage and achieve anticipated synergies and operational efficiencies in connection with completed and future, if any, divestitures, mergers, acquisitions, and other portfolio management, productivity and infrastructure actions; (vii) risks and uncertainties, including increased costs and the ability to obtain raw materials and meet customer needs from, among other events, pandemics and responsive actions; timing and recovery from demand declines in consumer-facing markets, including in China; adverse changes in worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions; and other factors beyond the Company's control, including inflation, recession, military conflicts, natural and other disasters or weather related events, that impact the operations of the Company, its customers and/or suppliers; (viii) ability to offset increases in cost of inputs, including raw materials, energy and logistics; (ix) risks associated with demand and market conditions in the semiconductor industry and associated end markets, including from continuing or expanding trade disputes or restrictions, including on exports to China of U.S.-regulated products and technology; (x) risks, including ability to achieve, and costs associated with DuPont's sustainability strategy including the actual conduct of the company's activities and results thereof, and the development, implementation, achievement or continuation of any goal, program, policy or initiative discussed or expected; and (xi) other risks to DuPont's business and operations, including the risk of impairment; each as further discussed in DuPont's most recent annual report and subsequent current and periodic reports filed with the U.S. Securities and Exchange Commission. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business or supply chain disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont's consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Non-GAAP Financial Measures
Unless otherwise indicated, all financial metrics presented reflect continuing operations only.

This communication includes information that does not conform to accounting principles generally accepted in the United States of America ("U.S. GAAP") and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company, including allocating resources. DuPont's management believes these non-GAAP financial measures are useful to investors because they provide additional information related to the ongoing performance of DuPont to offer a more meaningful comparison related to future results of operations. These non-GAAP financial measures supplement disclosures prepared in accordance with U.S. GAAP, and should not be viewed as an alternative to U.S. GAAP. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Reconciliations for these non-GAAP measures to U.S. GAAP are provided in the Selected Financial Information and Non-GAAP Measures starting on page 11 and in the Reconciliation to Non-GAAP Measures on the Investors section of the Company's website. Non-GAAP measures included in this communication are defined below. The Company has not provided forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of certain future events. These events include, among others, the impact of portfolio changes, including asset sales, mergers, acquisitions, and divestitures; contingent liabilities related to litigation, environmental and indemnifications matters; impairments and discrete tax items. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.

Indirect costs, such as those related to corporate and shared service functions previously allocated to the Delrin® Divestiture, do not meet the criteria for discontinued operations and were reported within continuing operations in the respective prior years. A portion of these historical indirect costs include costs related to activities the Company is undertaking on behalf of Delrin® and for which it is reimbursed ("Future Reimbursable Indirect Costs"). Future Reimbursable Indirect Costs are reported within continuing operations but are excluded from operating EBITDA as defined below. The remaining portion of these indirect costs is not subject to future reimbursement ("Stranded Costs"). Stranded Costs are reported within continuing operations in Corporate & Other and are included within Operating EBITDA.

Adjusted Earnings (formerly referred to as "Adjusted results") is defined as income from continuing operations excluding the after-tax impact of significant items, after-tax impact of amortization expense of intangibles, the after-tax impact of non-operating pension / other post employment benefits ("OPEB") credits / costs and Future Reimbursable Indirect Costs. Adjusted Earnings is the numerator used in the calculation of Adjusted EPS, as well as the denominator in Adjusted Free Cash Flow Conversion.

Adjusted EPS is defined as Adjusted Earnings per common share - diluted. Management estimates amortization expense in 2024 associated with intangibles to be about $600 million on a pre-tax basis, or approximately $1.10 per share.

The Company's measure of profit/loss for segment reporting purposes is Operating EBITDA as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines Operating EBITDA as earnings (i.e., "Income from continuing operations before income taxes") before interest, depreciation, amortization, non-operating pension / OPEB benefits / charges, and foreign exchange gains / losses, excluding Future Reimbursable Indirect Costs, and adjusted for significant items. Reconciliations of these measures are provided on the following pages.

Operating EBITDA Margin is defined as Operating EBITDA divided by Net Sales.

Significant items are items that arise outside the ordinary course of the Company's business that management believes may cause misinterpretation of underlying business performance, both historical and future, based on a combination of some or all of the item's size, unusual nature and infrequent occurrence. Management classifies as significant items certain costs and expenses associated with integration and separation activities related to transformational acquisitions and divestitures as they are considered unrelated to ongoing business performance.

Organic Sales is defined as net sales excluding the impacts of currency and portfolio.

Adjusted Free Cash Flow is defined as cash provided by/used for operating activities from continuing operations less capital expenditures and excluding the impact of cash inflows/outflows that are unusual in nature and/or infrequent in occurrence that neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business liquidity. As a result, adjusted free cash flow represents cash that is available to the Company, after investing in its asset base, to fund obligations using the Company's primary source of liquidity, cash provided by operating activities from continuing operations. Management believes adjusted free cash flow, even though it may be defined differently from other companies, is useful to investors, analysts and others to evaluate the Company's cash flow and financial performance, and it is an integral measure used in the Company's financial planning process. Management notes that there were no exclusions for items that are unusual in nature and/or infrequent in occurrence for the three-month periods ended March 31, 2024 and March 31, 2023.

Adjusted Free Cash Flow Conversion is defined as Adjusted Free Cash Flow divided by Adjusted Earnings. Management uses Adjusted Free Cash Flow Conversion as an indicator of our ability to convert earnings to cash. The Company updated its definition of Adjusted Free Cash Flow Conversion in the fourth quarter 2023 and all periods were recast to reflect the change. Refer to Reconciliation to Non-GAAP Measures under the Events & Presentation tab on the Investors section of the Company's website for the recast information

DuPont Reports Third Quarter 2023 Results

https://s23.q4cdn.com/116192123/files/doc_financials/2023/q3/3Q23-DuPont-Earnings-News-Release-vF.pdf

I replied on the LWLG board but the post was deleted.
One of the best health sites is the Life Extension Foundation:

https://www.lifeextension.com/

Dr Faloon, one of founders, has started taking anti-aging supplements. Here is his latest presentation on anti-aging:
Search RAADfest 2022 Bill Faloon Age Reversal Research Progress, on utube to get it to work.


One of the best books is Dr Stephen Sinatra's book, The Sinatra Solution: Metabolic Cardiology.

I replied on the LWLG board but the post was deleted.
One of the best health sites is the Life Extension Foundation:
https://www.lifeextension.com/

Dr Faloon, one of founders, has started taking anti-aging supplements. Here is his latest presentation on anti-aging:


One of the best books is Dr Stephen Sinatra's book, The Sinatra Solution: Metabolic Cardiology.

Liable for previous corporation's pollution.

https://appellate.nccourts.org/opinions/?c=1&pdf=41896

Just trying to figure out what's going on here...




Enablence Acquires DuPont Photonics Through Asset Deal and
July 31, 2008 at 9:16 AM MDT
Share this article
New
Gift this article
Enablence Acquires DuPont Photonics Through Asset Deal and DuPont
Invests $US 5M

https://www.bloomberg.com/press-releases/2008-07-31/enablence-acquires-dupont-photonics-through-asset-deal-and


Enablence is still around...
Enablence Technologies Announces Results from Annual and Special Shareholders' Meeting
Newsfile Corp.
Wed, December 7, 2022 at 2:05 p.m.+++

https://ca.finance.yahoo.com/news/enablence-technologies-announces-results-annual-210500137.html

Hmm what happened to the sock price after this?

Very strange tape after market today...

Trades>=1K today...


12/08/22 19:00:00 69.85 69.40 70.29 495,100
12/08/22 18:30:00 69.85 69.41 70.29 495,100
12/08/22 16:10:00 69.85 68.00 71.00 495,100
12/08/22 16:03:21 69.85 68.00 71.00 1,400
12/08/22 16:03:21 69.85 68.00 71.00 1,600
12/08/22 16:03:21 69.85 68.00 71.00 4,800
12/08/22 16:03:21 69.85 68.00 71.00 2,000
12/08/22 16:03:21 69.85 68.00 71.00 2,100
12/08/22 16:03:20 69.85 68.00 71.00 7,700
12/08/22 16:03:19 69.85 68.00 71.00 3,800
12/08/22 16:03:19 69.85 68.00 71.00 2,200
12/08/22 16:03:19 69.85 68.00 71.00 495,100
12/08/22 16:03:18 69.85 68.00 71.00 495,100
12/08/22 15:59:25 69.82 69.81 69.82 1,400
12/08/22 15:58:39 69.83 69.81 69.82 1,600
12/08/22 15:55:18 69.74 69.73 69.74 1,100
12/08/22 15:54:01 69.68 69.65 69.66 1,000
12/08/22 15:53:46 69.67 69.66 69.67 1,400
12/08/22 15:45:38 69.59 69.58 69.59 1,100
12/08/22 15:44:04 69.65 69.64 69.66 1,143
12/08/22 15:43:42 69.63 69.63 69.64 1,200
12/08/22 15:43:23 69.62 69.62 69.63 1,000
12/08/22 15:40:12 69.62 69.61 69.62 1,000
12/08/22 15:14:19 69.81 69.77 69.80 1,687
12/08/22 14:56:37 69.9151 69.91 69.93 1,500
12/08/22 14:52:39 69.875 69.86 69.89 87,524
12/08/22 14:51:23 69.803 69.79 69.81 1,000
12/08/22 14:40:05 69.83 69.82 69.84 1,000
12/08/22 14:26:11 69.84 69.84 69.86 1,000
12/08/22 14:16:02 69.74 69.73 69.76 3,100
12/08/22 14:00:59 70.145 70.13 70.16 1,400
12/08/22 13:52:40 70.23 70.22 70.25 1,000
12/08/22 13:49:22 70.28 70.25 70.28 1,220
12/08/22 13:29:22 70.1801 70.20 70.22 5,300
12/08/22 13:29:01 70.18 70.18 70.20 1,700
12/08/22 13:15:29 70.1601 70.16 70.18 1,000
12/08/22 13:13:09 70.23 70.22 70.23 1,000
12/08/22 12:57:31 70.16 70.14 70.16 1,000
12/08/22 12:52:35 70.09 70.08 70.10 1,100
12/08/22 12:41:10 70.0894 70.08 70.10 1,000
12/08/22 12:30:15 70.13 70.13 70.16 1,400
12/08/22 11:57:01 70.2639 70.25 70.29 1,000
12/08/22 11:48:13 70.24 70.24 70.26 1,000
12/08/22 11:45:30 70.205 70.19 70.22 1,131
12/08/22 11:33:26 70.27 70.28 70.31 3,900
12/08/22 11:31:21 70.23 70.21 70.23 1,000
12/08/22 11:26:11 70.005 69.99 70.02 2,100
12/08/22 11:26:11 70.005 69.99 70.02 2,700
12/08/22 11:09:46 70.36 70.33 70.35 7,563
12/08/22 11:03:56 70.4042 70.39 70.42 1,600
12/08/22 11:03:48 70.355 70.34 70.37 1,100
12/08/22 10:53:38 70.56 70.54 70.56 1,200
12/08/22 10:47:36 70.55 70.52 70.54 1,000
12/08/22 10:46:57 70.52 70.50 70.53 1,000
12/08/22 10:45:43 70.4927 70.47 70.51 1,400
12/08/22 10:40:36 70.49 70.49 70.53 3,800
12/08/22 10:37:24 70.63 70.62 70.65 1,300
12/08/22 10:35:30 70.60 70.60 70.63 1,000
12/08/22 10:20:42 70.57 70.55 70.59 1,000
12/08/22 09:54:56 70.59 70.56 70.60 1,064
12/08/22 09:53:50 70.515 70.49 70.55 2,376
12/08/22 09:52:57 70.43 70.43 70.49 1,700
12/08/22 09:49:12 70.36 70.30 70.39 1,400

Looks like they sold the polymer division:


Celanese will buy DuPont's engineering polymer and elastomer businesses for $11 billion – Chemical & Engineering News
September 9, 2022 by Civil Engg Notes

In a deal that will combine two of the world’s leading engineering polymer businesses, Celanese has agreed to acquire most of DuPont’s Mobility and Materials unit for $11 billion.

The businesses, which DuPont earmarked for sale in November, had sales of $3.5 billion and profit before taxes of $800 million in 2021. The acquisition will be a major one for Celanese, which had sales of $8.5 billion last year, and will more than double the size of the firm’s engineered materials unit.
Roughly 5,000 employees and 29 manufacturing sites will move to Celanese in the deal, which the companies aim to complete around year-end.
The transaction includes many materials used in demanding applications, such as automotive and electronics parts. One key polymer is nylon 6,6, which has been a part of DuPont for over 80 years. DuPont sold its nylon fiber business in 2004. In addition, Celanese will get DuPont’s long-chain and performance nylons, polybutylene terephthalate, and polyethylene terephthalate. DuPont’s polyester and ethylene acrylic elastomers and its Mylar and Melinex polyester films are also part of the deal.
“This is a very high-quality business,” Scott Richardson, Celanese’s chief financial officer, said on a Feb. 18 conference call with analysts. “A high-margin business that very much kind of fits hand and glove with our engineered materials business.”
Celanese’s engineering polymer line includes polyacetal, ultra-high-molecular-weight polyethylene, liquid crystal polymers, and polyphenylene sulfide. DuPont’s nylon and polybutylene terephthalate production will provide raw material for Celanese’s compounding operations in those areas.
The purchase will also extend Celanese’s reach in Asia, helping the firm recover some of the presence it relinquished in 2020 when it sold its stake in the Polyplastics joint venture with Japan’s Daicel. Overall, Celanese executives say, the firm will achieve $450 million worth of annual benefits by integrating the DuPont polymer business with its own.
Celanese has been pushing to grow its engineered materials business. Late last year, it bought ExxonMobil’s Santoprene thermoplastic vulcanizate business for $1.15 billion.
Celanese and DuPont left DuPont’s Delrin polyacetal business out of the deal to ease approval from antitrust authorities. Celanese’s Richardson told analysts that he doesn’t expect regulators to require any meaningful concessions before approving the transaction.
DuPont now plans to separately market the Delrin business, which has annual sales of about $550 million. “There is substantial interest in this high-quality asset,” DuPont CEO Edward Breen says in a statement. The company expects to sell that business by the first quarter of 2023.
Tedlar polyvinyl fluoride films, used on solar panels, were also left out of the sale. DuPont says it will keep that business, as well as its auto adhesive and Multibase polymer additive businesses.
DuPont plans to use the sale proceeds to pay for its pending $5.2 billion purchase of the electronic materials firm Rogers and to finance further acquisitions and share buybacks.
Stock analysts say the deal will indeed be transformational for Celanese. With the DuPont businesses, Celanese will have the “broadest and most differentiated” portfolio of engineered materials in the world, Frank J. Mitsch of Fermium Research writes in a note to clients. In the process, Celanese’s more commodity-like acetyl chemical business will become “a smaller amount of the total pie.” Acetyls accounted for 64% of the firm’s sales in 2021.
In a report, Vertical Research Partners analyst Kevin W. McCarthy calls the purchase an “attractive strategic fit” for Celanese. “The transaction vaults Celanese to a different league on the global stage as it creates a world-class leader in engineered materials,” he writes.
McCarthy says the purchase may set the stage for future transactions. The scale that the DuPont business provides, he observes, could give Celanese “critical mass” to split off its acetyl business “at some point down the road after the incremental debt has been digested sufficiently.”
This article was originally published on Feb. 18, 2022. It was updated on Feb. 24, 2022, to include comment about the deal from stock analysts.
Article:

LWLG stockholder... curious about what's going on...

COBO + OPTICA Co-Packaged Optics and Pluggable Optics Industry Summit October 26-27, 2022

I worked there two summers at the Waynesboro plant while going to college.
They had a training program for new hires back in the 60's and a good retirement plan.
My father worked for them for 42 years.
Benger Labs was one of DuPonts better labs. Some of the best nylon was made there due to the water quality from Baker Springs, an artesian spring.
Here is a history piece I found:
https://walterwilson3.com/f/the-waynesboro-du-pont-plant

Dupont

Used to be a good company...... now just a has been..... and pretty soon a never was......

PPD where are you? All semi works buildings by the Brandywine gone.....
the history....... gone......

Thanks Woolard...... Thanks Chad on Holiday.......

Goodbye best company I ever worked for...... but at least I got 20 years out of it. Most will never know what a great company was...... took care of their people...... now money over people...... 249 building and yard gang where I started..... I'll never forget you...... ever.

Short to $70

looking good

Short to $70

86